EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 6135

Chapter 6135 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.



Saitta A.; Coglitore G.; De Leo A.; Mangano C.; Trifiletti A.; Pizzoleo M.A.; Iauk L.; Galati E.M.; Squadrito G., 1980: Platelet aggregation and plasma catecholamine in young healthy people after exertion test

Yamada K.; Mori K.; Goto Y., 1981: Platelet aggregation and plasma levels of beta thrombo globulin in diabetes mellitus

Desai K.; Owen J.S.; Wilson D.T.; Hutton R.A., 1986: Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal

Terranova, R.; Tribulato, A.; Di-Stefano, A., 1978: Platelet aggregation and plasma viscosity in diabetic vasculopathy

Adam O.; Dill Wiessner M.; Wolfram G.; Zoellner N., 1980: Platelet aggregation and prostaglandin turnover in man during defined linoleic acid supply with formula diets

Clark W.F.; Tevaarwerk G.J.M.; Reid B.D., 1980: Platelet aggregation and release associated with immune complex formation in pig plasma


Lacerda V.P.; Lima Filho J.L.; Gillett M.P.T., 1986: Platelet aggregation and release induced by saponins and related substances

Ingeberg S.; Jacobsen P.; Fischer E.; Bentsen K.D., 1985: Platelet aggregation and release of atp in patients with hepatic cirrhosis

Khosla P.K.; Mahabaleswara M.; Tiwari H.K.; Saraya A.K., 1979: Platelet aggregation and retinal micro angiopathy in diabetes and hypertension

Silbearbauer K.; Schernthaner G.; Sinzinger H.; Freyler H., 1981: Platelet aggregation and reversible platelet aggregates in type i diabetes staged by retinal fluorescein angiography

Turlubekov K.K.; Osipov S.G.; Kasatkina L.V.; Titov V.N., 1982: Platelet aggregation and serum immune complexes in ischemic heart disease

Calabrese S.; Giansante C.; Cattin L.; Tonini G.; Tecilazich D.; Renier S.; Pocecco M.; Perissutti P.; Borzaghini L., 1983: Platelet aggregation and some metabolic parameters in young diabetics type i with and without retinopathy

Kurpiewski G.; Forrester L.J.; Barrett J.T.; Campbell B.J., 1981: Platelet aggregation and sphingomyelinase d activity of a purified toxin from the venom of loxosceles reclusa

Miragliotta G.; Fumarola D.; Colucci M.; Semeraro N., 1981: Platelet aggregation and stimulation of leukocyte pro coagulant activity by rickettsial lipo poly saccharides in rabbits and man

Poller, L.; Priest, C. M.; Thomson, J. M., 1971: Platelet aggregation and strenuous exercise

Mustafina S.M., 1980: Platelet aggregation and the blood coagulation system in children with glomerulo nephritis

Wang, T. Y.; Hussey, C. V.; Sasse, E. A.; Hause, L. L., 1977: Platelet aggregation and the ouabain insensitive atpase ecto atpase reflection of membrane integrity

Tirelli, A.; Coppola, L.; Misso, L.; Chianese, U., 1978: Platelet aggregation and thrombo elastography in secondary thrombocytosis

Colman, R. W., 1975: Platelet aggregation and thrombotic vascular disease

Marcinkiewicz, E.; Grodzinska, L.; Gryglewski, R. J., 1978: Platelet aggregation and thromboxane a 2 formation in cat platelet rich plasma

Serneri G.G.N.; Abbate R.; Gensini G.F.; Galanti G.; Paoli G.; Laureano R., 1982: Platelet aggregation and thromboxane a 2 production after adrenergic stimulation in young healthy humans

Mikhailidis D.P.; Fonseca V.; Barradas M.A.; Hutton R.A.; Jeremy J.Y.; Epstein O.; Mcintyre N.; Dandona P., 1988: Platelet aggregation and thromboxane a 2 release in primary biliary cirrhosis and effect of d penicillamine treatment

Hillbom M.E.; Kangasaho M.; Hjelm Jager M., 1984: Platelet aggregation and thromboxane b 2 formation after ethanol abuse is there a relationship to stroke

Takatsu Y.; Yui Y.; Hattori R.; Sakaguchi K.; Susawa T.; Yui N.; Takahashi M.; Aoyama T.; Tamaki S.; Kawai C., 1988: Platelet aggregation and thromboxane b 2 release in patients with acute myocardial infarction their relation to coronary patency

Kuester, L. J.; Froelich, J. C., 1986: Platelet aggregation and thromboxane release induced by arachidonic acid collagen adp and platelet activating factor following low dose acetylsalicylic acid in man

Rosenblum, W. I.; El-Sabban, F., 1978: Platelet aggregation and vaso constriction in undamaged micro vessels on cerebral surface adjacent to brain traumatized by a penetrating needle

Thibonnier M.; Woloschak M., 1988: Platelet aggregation and vasopressin receptors in patients with diabetes mellitus

Cowan, D. H.; Bowman, L. S.; Fratianne, R. B.; Ahmed, F., 1976: Platelet aggregation as a sign of septicemia in thermal injury a prospective study

Stornello, M.; Aloisi, B.; Stuto, A.; Vinci, E.; Bozzanca, L., 1978: Platelet aggregation before and after stress in infarction patients during rehabilitation

Petronio A.S.; Evangelisti L.; Preti R.; Gherarducci G.; Balbarini A.; Giordani R.; Mariani M., 1987: Platelet aggregation behavior in patients treated with ticlopidine

Fritschi J.; Christe M.; Lammle B.; Marbet G.A.; Berger W.; Duckert F., 1984: Platelet aggregation beta thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy

Coutinho I.R.; Berk R.S.; Mammen E., 1988: Platelet aggregation by a phospholipase c from pseudomonas aeruginosa

Barnes, M. J.; Bailey, A. J.; Gordon, J. L.; Macintyre, D. E., 1980: Platelet aggregation by basement membrane associated collagens

Mcmanama G.; Lindon J.N.; Kloczewiak M.; Smith M.A.; Ware J.A.; Hawiger J.; Merrill E.W.; Salzman E.W., 1986: Platelet aggregation by fibrinogen polymers crosslinked across the e domain

Usui Y.; Ohshima Y.; Yoshida K., 1987: Platelet aggregation by group b streptococci

Daugharty H.; Gogel R., 1976: Platelet aggregation by hepatitis b surface antigen antibody complexes

Chang, H. N.; Robertson, C. R., 1976: Platelet aggregation by laminar shear and brownian motion

Kurpiewski G.E.; Forrester L.J.; Campbell B.J.; Barrett J.T., 1983: Platelet aggregation by streptococcus pyogenes

Caen, J. P., 1976: Platelet aggregation by thimerosal

Leone, G.; Boni, P.; Vincenti, A., 1976: Platelet aggregation by thimerosal role of adp and sulfhydryl groups

Azuma H.; Sekizaki S.; Satoh A.; Nakajima T.; Ishikawa M., 1986: Platelet aggregation caused by a partially purified jellyfish toxin from carybdea rastonii

Azuma H.; Sekizaki S.; Satoh A.; Nakajima T., 1986: Platelet aggregation caused by carybdea rastonii toxins i ii and iii obtained from a jellyfish carybdea rastonii

Zucker M.B.; Masiello N.C., 1984: Platelet aggregation caused by di thio threitol

Berrebi A.; Vorst E.; Shtalrid M.; Resnitzky P.; Nir E., 1984: Platelet aggregation defect in megakaryoblastic leukemia

Yamazaki H.; Motomiya T.; Kikutani N.; Sakakibara C.; Watanabe S.; Numata M.; Noguchi K., 1979: Platelet aggregation during menstrual cycle and pregnancy

Schumacher K.A.; Classen H.G.; Spaeth M., 1979: Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lyso derivatives identity with substances in aged serum depressor active substance

Slade, C. L.; Andes, W. A.; Mason, A. D-Jr, 1976: Platelet aggregation following de fibrination with ancrod

Iatridis S.G.; Iatridis P.G.; Kyrkou K.A.; Markidou S.G.; Iatridi I.S., 1979: Platelet aggregation following exposure of phospho lipase treated platelet rich plasma to hydrogen per oxide

Ellison, N.; Edmunds, L. H. Jr ; Colman, R. W., 1978: Platelet aggregation following heparin and protamine administration

Van Wersch J.; Pereira R.R., 1983: Platelet aggregation in 6 families with bartters syndrome

Yu G R.; Liang G R.; Huang M X.; Zheng D S.; Huang D J.; Zhong D S.; Xie X L.; Yao G D.; Zhang J L.; Et Al, 1985: Platelet aggregation in 93 cases of coronary heart disease

Mehta, J.; Mehta, P.; Pepine, C. J., 1978: Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease part 3 role of tachy cardia stress and propranolol

Herrmann K.S.; Seuter F., 1984: Platelet aggregation in arterioles of the hamster cheek pouch and in heart transplants its tissue dependent influencibility by acetyl salicylic acid and nafazatrom

Rosenblum W.I.; Wei E.P.; Kontons H.A., 1982: Platelet aggregation in cerebral arterioles after percussive brain trauma

Heyns, A. D. P.; Fraser, J.; Retief, F. P., 1978: Platelet aggregation in chronic idiopathic thrombocytopenic purpura

Davi, G.; Avellone, G.; Di-Liberti, M.; Novo, S., 1976: Platelet aggregation in clinical medicine validity of breddins method

Ozsoylu, S.; Hicsonmez, G., 1976: Platelet aggregation in congenital factor xiii deficiency

Barberis G.; Gaffuri M.; Mattiauda M.; Paparo R., 1984: Platelet aggregation in coronary artery disease patients

Pastorova, V. E., 1976: Platelet aggregation in depression and activation of the anti coagulation system in animals

Giansante C.; Calabrese S.; Cattin L.; Feruglio F.S.; Ponte E., 1981: Platelet aggregation in diabetes mellitus

Miralles Garcia J.M.; Pablo Davilla F.; Sanchez Martin S.; Alberca Silva I., 1980: Platelet aggregation in diabetes mellitus in connection with diabetic retinopathy

Janka H.U.; Standl E., 1979: Platelet aggregation in diabetic coma relation to cyclic amp levels and prostacyclin stimulated activity of platelet adenylate cyclase

Creter, D.; Pavlotzky, F.; Savir, H., 1978: Platelet aggregation in diabetic retinopathy

Jones B E.V., 1984: Platelet aggregation in dogs after live virus vaccination

Luo C.; Et Al, 1986: Platelet aggregation in experimental atherosclerosis

Goodman J.H.; Bingham W.G.Jr; Hunt W.E., 1979: Platelet aggregation in experimental spinal cord injury ultrastructural observations

Salo M.K.; Vartiainen E.; Puska P.; Nikkari T., 1985: Platelet aggregation in finnish men and its relation to fatty acids in platelets plasma and adipose tissue

Grabowski, E. F., 1978: Platelet aggregation in flowing blood in vitro part 1 production by controlled adp convective diffusion and quantification by video densitometry

Grabowski, E. F.; Franta, J. T.; Didisheim, P., 1978: Platelet aggregation in flowing blood in vitro part 2 dependence of aggregate growth rate on adp concentration and shear rate

Hansen P.E.; Hansen J.H.; Stenbjerg S., 1982: Platelet aggregation in focal cerebral ischemia a clinical study

Rai R.; Pati H.; Arya L.S.; Saraya A.K., 1987: Platelet aggregation in homozygous beta thalassemia

De La Cruz J.P.; Camara S.; Bellido I.; Carrasco T.; Sanchez De La Cuesta F., 1987: Platelet aggregation in human whole blood after chronic administration of aspirin

Yung, W.; Frojmovic, M. M., 1982: Platelet aggregation in laminar flow 1. adp concentration time and shear rate dependence

Yung, W.; Frojmovic, M. M., 1982: Platelet aggregation in laminar flow 2. shear rate and adp dependent effects of acetyl salicylic acid and indomethacin

Barrantes A.; Marten A.; Montero C.; Cordero R., 1980: Platelet aggregation in liver disease induced by alcohol

Schapira A.H.V.; Hutton R.A., 1985: Platelet aggregation in myotonia

Musumeci V.; Carloni L.; Marchetti P.; Zappacosta B.; Marra R.; Ricerca B.M., 1981: Platelet aggregation in native blood exposed to a shifting shear rate field

Hicsonmez G.; Prozorova Zamani V., 1980: Platelet aggregation in neo nates with hyper bilirubinemia

Folts, J. D.; Crowell, E. B. Jr ; Rowe, G. G., 1976: Platelet aggregation in partially obstructed vessels and its elimination with aspirin

Rosenberg H.; Fisher C.A.; Reed S.B.; Addonizio V.P., 1981: Platelet aggregation in patients susceptible to malignant hyper thermia

Gabrielyan E.S.; Akopov S.E.; Tunyan Yu S.; Nazaryan A.V., 1985: Platelet aggregation in patients with acute disorders of cerebral circulation

Kobayashi M.; Okushin S.; Toi S.; Usui K.; Tada M.; Arita M.; Yorioka N.; Yamakido M., 1984: Platelet aggregation in patients with chronic glomerulonephritis

Titova S.I.; Gincherman E.Z., 1979: Platelet aggregation in patients with diabetes mellitus at various stages of the development of retinopathy

Maki Y.; Nose T.; Tanoue K.; Abe T., 1981: Platelet aggregation in patients with moyamoya disease

Davtyan D.G.; Amroyan E.A.; Gabrielyan E.S., 1985: Platelet aggregation in patients with periodic disease during the course of hyperbaric oxygenation

Ward, A. S.; Porter, N.; Preston, F. E.; Morris-Jones, W., 1978: Platelet aggregation in patients with peripheral vascular disease

Olcott, C. Iv ; Wylie, E. J., 1978: Platelet aggregation in patients with severe athero sclerosis/

Amroyan E.A., 1987: Platelet aggregation in plasma and whole blood during hyperventilation hypocapnia in cats

Agwu D.E.; Holub B.J.; Johnstone I.B.; Crane S., 1983: Platelet aggregation in platelet suspensions from mongolian gerbils meriones unguiculatus

Bell, D. N.; Teirlinck, H. C.; Goldsmith, H. L., 1984: Platelet aggregation in poiseuille flow 1. a double infusion technique

Bell, D. N.; Goldsmith, H. L., 1984: Platelet aggregation in poiseuille flow 2. effect of shear rate

Vaverkova H.; Weinbergova O.; Kubasta M.; Horcicka V.; Jezdinsky J., 1985: Platelet aggregation in primary hyperlipoproteinemia

Walker R.I.; Shields L.J.; Fletcher J.R., 1978: Platelet aggregation in rabbits made tolerant to endo toxin

Winocour, P. D.; Turner, M. R.; Taylor, T. G.; Munday, K. A., 1978: Platelet aggregation in rats in relation to hyper uricemia induced by dietary single cell protein and to protein deficiency

Vlachakis N.D.; Aledort L., 1979: Platelet aggregation in relationship to plasma catecholamines in patients with hypertension

Gabbasov Z.A.; Popov E.G.; Nekrasova A.A.; Runikhin A.Yu, 1987: Platelet aggregation in severe and malignant arterial hypertension the effect of treatment with prostaglandin e 2

Rosenblum, W. I.; El-Sabban, F., 1977: Platelet aggregation in the cerebral micro circulation effect of aspirin and other agents

Takahara K.; Nakashima Y.; Takei S.; Takasugi M.; Kuroiwa A., 1984: Platelet aggregation in variant angina its relation to plasma catecholamines

Fox S.C.; Burgess Wilson M.; Heptinstall S.; Mitchell J.R.A., 1982: Platelet aggregation in whole blood determined using the ultra flo 100 platelet counter

Burgess-Wilson, M. E.; Cockbill, S. R.; Johnston, G. I.; Heptinstall, S., 1987: Platelet aggregation in whole blood from patients with glanzmann's thrombasthenia

Carter A.J.; Heptinstall S., 1985: Platelet aggregation in whole blood the role of thromboxane a 2 and adp

Tamaoki J.; Sekizawa K.; Osborne M.L.; Ueki I.F.; Graf P.D.; Nadel J.A., 1987: Platelet aggregation increases cholinergic neurotransmission in canine airway

Holmberg L.; Nilsson I.M.; Borge L.; Gunnarsson M.; Sjorin E., 1983: Platelet aggregation induced by 1 desamino 8 d arginine vasopressin in type iib von willebrands disease

Wang, T. Y.; Hussey, C. V.; Hause, L. L.; Fobian, J. E., 1976: Platelet aggregation induced by anti lymphocyte serum part 2 2 modes of the aggregation mechanism

Takahashi, H.; Okada, K.; Abe, S.; Wada, K.; Nagayama, R.; Tatewaki, W.; Hanano, M.; Takizawa, S. I.; Shibata, A., 1987: Platelet aggregation induced by cryoprecipitate infusion in platelet type von willebrand's disease

Tokumura, A.; Yoshida, J. I.; Maruyama, T.; Fukuzawa, K.; Tsukatani, H., 1987: Platelet aggregation induced by ether linked phospholipids 1. inhibitory actions of bovine serum albumin and structural analogues of platelet activating factors

Tokumura, A.; Yoshida, J. I.; Okasaka, N.; Fukuzawa, K.; Tsukatani, H., 1987: Platelet aggregation induced by ether linked phospholipids 2. mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists

Ono Y.; Misawa K.; Kudoh M.; Nakagawa S., 1986: Platelet aggregation induced by the platelet aggregation factor paf in normal and diabetic patients

Nakayama T.; Nakamura W., 1984: Platelet aggregation induced in mice by whole body hyper thermia

Hermann K.S., 1983: Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein iso thio cyanate dextran

Chater, B. V.; Williams, A. R., 1977: Platelet aggregation induced in vitro by therapeutic ultrasound

Rehse, K.; Werner, U., 1986: Platelet aggregation inhibiting and anticoagulant effects of oligoamines i. n 4 piperidinylmethanamines

Rehse, K.; Luekens, U., 1986: Platelet aggregation inhibiting and anticoagulant effects of oligoamines ii. 1 4 phenylenebisalkanamines

Rehse, K.; Luekens, U.; Leissring, S.; Claus, G., 1987: Platelet aggregation inhibiting and anticoagulant effects of oligoamines iii. 1 3 phenylenebisalkanamines

Rehse, K.; Carstensen, A.; Ernst, H. J., 1987: Platelet aggregation inhibiting and anticoagulant effects of oligoamines iv. n n' bisarylalkylalkanediamines

Rehse, K.; Carstensen, A.; Ernst, H. J., 1987: Platelet aggregation inhibiting and anticoagulant effects of oligoamines v. alicyclic diamines and triamines

Rehse, K.; Claus, G.; Leissring, S., 1987: Platelet aggregation inhibiting and anticoagulant effects of oligoamines vi. oligohydroxyalkanediamines

Rehse, K.; Luekens, U.; Claus, G., 1987: Platelet aggregation inhibiting and anticoagulant effects of oligoamines vii. benzene 1 3 5 trialkanamines

Feins R.H.; Roedersheimer L.R.; Green R.M.; Deweese J.A., 1979: Platelet aggregation inhibition in human umbilical vein grafts and negatively charged bovine hetero grafts

Coan M.L.; Case K.R.; Bosmann H.B., 1982: Platelet aggregation inhibition of secondary aggregation by phenol

Ouyang C.; Huang T F., 1986: Platelet aggregation inhibitors from agkistrodon acutus snake venom

Nishiya H.; Ishiwata K.; Komatsu K.; Nakata O.; Kitamura K.; Fujii S., 1988: Platelet aggregation inhibitors from jyu yaku houttuyniae herb

Gastpar H.; Ambrus J.L.; Ambrus C.M., 1981: Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease a review of experimental and clinical investigations

Kikugawa, K.; Suehiro, H.; Aoki, A., 1977: Platelet aggregation inhibitors part 10 s substituted 2 thio adenosines and their derivatives

Kikugawa, K.; Suehiro, H.; Aoki, A., 1977: Platelet aggregation inhibitors part 8 2 thio adenine derivatives

Kikugawa, K.; Suehiro, H.; Yanase, R.; Aoki, A., 1977: Platelet aggregation inhibitors part 9 chemical transformation of adenosine into 2 thio adenosine derivatives

O-Yang, C.; Wu, H. Y.; Kertesz, D. J.; Kluge, A. F.; Wallach, M. B.; Willis, A. L.; Smith, D. L.; Chang, L. F. K., 1987: Platelet aggregation inhibitory activity and vasodepressor activity of a series of bicyclo 3.2.0 hept 6 ylideneiminoxy alkanoic acids with modified lower side chains

Jorgensen K.A.; Kemp E.; Barfort P.; Starklint H.; Larsen S.; Munk Anderson G., 1986: Platelet aggregation is not essential for xenograft rejection

Legrand C.; Dubernard V.; Caen J., 1984: Platelet aggregation its relation with adp induced fibrinogen binding to platelets and adp related membrane enzyme activities

Martos E.; Pucsok J.; Malomosoki J.; Ekes E.; Hoffmann A., 1988: Platelet aggregation lipids and excretion of catecholamines after acute physical exercise in patients with myocardial infarction

Buchanan G.R.; Holtkamp C.A., 1981: Platelet aggregation malondialdehyde generation and production time in children with sickle cell anemia

Pagnan A.; Faggiotto A.; Visona A.; Davanzo S.; Pessina A.C.; Dal Palu C., 1980: Platelet aggregation measured by the screen filtration pressure method in hypertensive patients

Nicholas A.R.; Bosmann H.B., 1979: Platelet aggregation newly quantified using nonempirical parameters

Soria J.; Soria C.; Borg J.Y.; Mirshahi M.; Piguet H.; Tron P.; Fessard C.; Caen J.P., 1985: Platelet aggregation occurs in congenital afibrinogenemia despite the absence of fibrinogen or its fragments in plasma and platelets as demonstrated by immunoenzymology

Calabrese S.; Giansante C.; Benedetti A., 1982: Platelet aggregation platelet factor 4 and beta thrombo globulin in congestive heart disease

Lu W.; Adachi I.; Kano K.; Yasuta A.; Toriizuka K.; Ueno M.; Horikoshi I., 1985: Platelet aggregation potentiators from cho rei polyporus umbellatus

Lecrubier C.; Scarabin P.Y.; Grauso F.; Samama M., 1980: Platelet aggregation related to age in diabetes mellitus

Kaiya H.; Imai H.; Muramatsu Y.; Nozaki M.; Fujimura H.; Adachi S.; Namba M., 1983: Platelet aggregation response in schizophrenia and prostaglandin e 1

Hutton R.A.; Mikhailidis D.; Dormandy K.M.; Ginsburg J., 1979: Platelet aggregation studies during transient hypo glycemia a potential method for evaluating platelet function

Mehta, J.; Mehta, P.; Burger, C.; Pepine, C. J., 1978: Platelet aggregation studies in coronary artery disease part 4 effect of aspirin

Yoshida T.; Hiroki T.; Arakawa K., 1983: Platelet aggregation studies in patients with angina pectoris relationships to types of angina and coronary patho anatomy

Saniabadi A.R.; Lowe G.D.O.; Forbes C.D.; Prentice C.R.M.; Barbenel J.C., 1983: Platelet aggregation studies in whole human blood

Samal' A.B.; Cherenkevich S.N.; Khmara N.F., 1982: Platelet aggregation under the effect of thrombin in low cell concentration solutions

Chetty N.; Reavis S.; Solomons H.D.; Pienaar N.; Baynes R.; Meriwether D.; Atkinson P.M., 1988: Platelet aggregations fatty acids clotting factors and serum lipids in rural and urban blacks and urban whites in south africa

Mikami, S.; Okuda, T.; Tokuda, S.; Murashita, N.; Takase, T.; Kamitsuzi, H., 1978: Platelet aggregations induced by ristocetin and bovine factor viii fraction in several kinds of congenital platelet disorders

Fiedel B.A., 1985: Platelet agonist synergism by the acute phase reactant c reactive protein

Gameron O.G.; Smith C.B.; Hollingsworth P.J.; Nesse R.M.; Curtis G.C., 1984: Platelet alpha 2 adrenergic receptor binding and plasma catecholamines before and during imipramine treatment in patients with panic anxiety

Kanof P.D.; Johns C.A.; Davidson M.; Siever L.J.; Coccaro E.F.; Davis K.L., 1988: Platelet alpha 2 adrenergic receptor function in psychiatric disorders

Stahl S.M.; Lemoine P.M.; Ciaranello R.D.; Berger P.A., 1983: Platelet alpha 2 adrenergic receptor sensitivity in major depressive disorder

Garcia Sevilla J.A.; Zis A.P.; Hollingsworth P.J.; Greden J.F.; Smith C.B., 1981: Platelet alpha 2 adrenergic receptors in major depressive disorder binding of tritium labeled clonidine before and after tri cyclic anti depressant drug treatment

Motulsky H.J.; O'connor D.T.; Insel P.A., 1983: Platelet alpha 2 adrenergic receptors in treated and untreated essential hypertension

Weiss R.J.; Tobes M.; Wertz C.E.; Smith C.B., 1983: Platelet alpha 2 adreno receptors in chronic congestive heart failure

Heufelder A.; Warnhoff M.; Pirke K.M., 1985: Platelet alpha 2 adrenoceptor and adenylate cyclase in patients with anorexia nervosa and bulimia

Theodorou A.E.; Mistry H.; Davies S.L.; Yamaguchi Y.; Horton R.W., 1987: Platelet alpha 2 adrenoceptor binding and function during the menstrual cycle

Sundaresan P.R.; Madan M.K.; Kelvie S.; Weintraub M., 1985: Platelet alpha 2 adrenoceptors and the menstrual cycle

Garcia Sevilla J.A.; Ugedo L.; Ulibarri I.; Gutierrez M., 1985: Platelet alpha 2 adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine

Sacchetti E.; Conte G.; Pennati A.; Vita A.; Alciati A.; Cazzullo C.L., 1985: Platelet alpha 2 adrenoceptors in major depression relationship with urinary 4 hydroxy 3 methoxyphenylglycol and age at onset

Villeneuve, A.; Berlan, M.; Lafontan, M.; Caranobe, C.; Boneu, B.; Rascol, A.; Montastruc, J. L., 1985: Platelet alpha 2 adrenoceptors in parkinson's disease decreased number in untreated patients and recovery after treatment

Doyle M.C.; George A.J.; Ravindran A.V.; Philpott R., 1985: Platelet alpha 2 adrenoreceptor binding in elderly depressed patients

Nachman, R. L.; Harpel, P. C., 1976: Platelet alpha 2 macro globulin and alpha 1 anti trypsin

Siever L.J.; Kafka M.S.; Targum S.; Lake C.R., 1984: Platelet alpha adrenergic binding and biochemical responsiveness in depressed patients and controls

Sundaresan P.R.; Weintraub M.; Hershey L.A.; Kroening B.H.; Hasday J.D.; Banerjee S.P., 1983: Platelet alpha adrenergic receptors in obesity alteration with weight loss

Rice H.E.; Smith C.B.; Silk K.R.; Rosen J., 1984: Platelet alpha adrenergic receptors in schizophrenic patients before and after phenothiazine treatment

Winther K.; Naesh O., 1987: Platelet alpha adrenoceptor function and aging

Pumphrey C.W.; Dawes J., 1983: Platelet alpha granule depletion findings in patients with prosthetic heart valves and following cardio pulmonary bypass surgery

Kaplan K.L.; Broekman M.J.; Chernoff A.; Lesznik G.R.; Drillings M., 1979: Platelet alpha granule proteins studies on release and sub cellular localization

Sacchi S.; Curci G.; Piccinini L.; Messerotti A.; Cucci F.; Bursi R.; Zaniol P.; Torelli U., 1986: Platelet alpha granule release in chronic myeloproliferative disorders with thrombocytosis

Sacchi S.; Curci G.; Piccinini L.; Cucci F.; Messerotti A.; Roncaia R.; Benedetti P.G., 1985: Platelet alpha granule release in diabetes mellitus

Kaplan D.R.; Chao F.C.; Stiles C.D.; Antoniades H.N.; Scher C.D., 1979: Platelet alpha granules contain a growth factor for fibroblasts

Taccola A.; Cipolli P.L.; Bossi M.C.; Gobba F.M.; Grampella D., 1980: Platelet alteration and carbon di sulfide poisoning adhesiveness

Ashby, B.; Holmsen, H., 1983: Platelet amp deaminase ec 3.5.4.6 regulation by magnesium atp and inorganic phosphate and inhibition by the transition state analog coformycin

Ashby B.; Holmsen H., 1981: Platelet amp deaminase purification and kinetic studies

Valdemarsson S.; Fagher B.; Hedner P.; Monti M.; Nilsson Ehle P., 1985: Platelet and adipocyte thermogenesis in hypothyroid patients a microcalorimetric study

Needleman P.; Wyche A.; Raz A., 1979: Platelet and blood vessel arachidonate metabolism and interactions

Maiello M.; Boeri D.; Bonadonna R.; Odetti P.; Saccarello A.; Adezati L., 1988: Platelet and clotting activities after cold stress in diabetic patients

Borsey D.Q.; Prowse C.V.; Gray R.S.; Dawes J.; James K.; Elton R.A.; Clarke B.F., 1984: Platelet and coagulation factors in proliferative diabetic retinopathy

Ludlam C.A.; Blandford R.B.; Dowdle R.; Bentley N.J.; Bloom A.L.; Allan N., 1981: Platelet and coagulation function in patients with abnormal cardiac valves treated with sulfinpyrazone

Bruni V.; Rosati D.; Bucciantini S.; Verni A.; Abbate R.; Pinto S.; Costanzo G.; Costanzo M., 1986: Platelet and coagulation functions during triphasic estrogen progestogen treatment

Wurzinger L.J.; Opitz R.; Blasberg P.; Schmid Schonbein H. , 1985: Platelet and coagulation parameters following millisecond exposure to laminar shear stress

Sengupta N.; Datta S.C.; Sengupta D.; Bal S., 1980: Platelet and erythrocyte membrane atpase activity in depressive and manic depressive illness

Sengupta N.; Datta S.C.; Sengupta D., 1981: Platelet and erythrocyte membrane lipid and phospho lipid patterns in different types of mental patients

Alving B.M.; Evatt B.L.; Levin J.; Bell W.R.; Ramsey R.B.; Levin F.C., 1979: Platelet and fibrinogen production relative sensitivities to endo toxin

Giller E.Jr; Nocks J.; Hall H.; Stewart C.; Schnitt J.; Sherman B., 1984: Platelet and fibroblast monoamine oxidase in alcoholism

Sussman, L. N., 1978: Platelet and granulocyte pheresis

Claas F.H.J.; Langerak J.; Van Vreeswijk W.; D'amaro J.; Van Rood J.J.; Balner H., 1983: Platelet and granulocyte specific allo antigens in chimpanzees

Fagiolo, E., 1976: Platelet and leukocyte antibodies in auto immune hemolytic anemia

Young N.; Gergely P.; Crawford N., 1981: Platelet and leukocyte calmodulins isolation and characterization

Pitkin R.M.; Witte D.L., 1979: Platelet and leukocyte counts in pregnancy

Sawada H.; Kamamoto T.; Yoshida Y.; Kita K.; Takayama H.; Kanaji K.; Okuma M.; Uchino H., 1986: Platelet and leukocyte lipoxygenase products in a patient with chronic granulocytic leukemia undergoing syngeneic bone marrow transplantation

Hechtman, H. B.; Lonergan, E. A.; Shepro, D., 1978: Platelet and leukocyte lung interactions in patients with respiratory failure

Martin J.F.; Slater D.N.; Kishk Y.T.; Trowbridge E.A., 1985: Platelet and megakaryocyte changes in cholesterol induced experimental atherosclerosis

Manwaring D.; Curreri P.W., 1982: Platelet and neutrophil sequestration after fragment d induced respiratory distress

Merritt J.E.; Hallam T.J., 1988: Platelet and parotid acinar cells have different mechanisms for agonist stimulated divalent cation entry

Murphy, D. L.; Wright, C.; Buchsbaum, M.; Nichols, A.; Costa, J. L.; Wyatt, R. J., 1976: Platelet and plasma amine oxidase activity in 680 normals sex and age differences and stability over time

Murphy, D. L.; Brand, E.; Goldman, T.; Baker, M.; Wright, C.; Van-Kammen, D.; Gordon, E., 1977: Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment

Boughton, B. J.; Allington, M. J.; King, A., 1978: Platelet and plasma beta thrombo globulin in myelo proliferative syndromes and secondary thrombocytosis

Larsson R.; Eriksson J C.; Lagergren H.; Olsson P., 1979: Platelet and plasma coagulation compatibility of heparinized and sulfated surfaces

Parbtaini A.; Frampton G.; Cameron J.S., 1980: Platelet and plasma serotonin concentrations in glomerulo nephritis 2

Parbtani A.; Cameron J.S., 1979: Platelet and plasma serotonin concentrations in glomerulo nephritis i

Parbtani, A.; Frampton, G.; Yewdall, V.; Kasai, N.; Cameron, J. S., 1980: Platelet and plasma serotonin in glomerulo nephritis 3. nephritis of systemic lupus erythematosus

Share L.; Crofton J.T.; Brooks D.P.; Chesney C.M., 1985: Platelet and plasma vasopressin in dog during hydration and vasopressin infusion

Jaschonek K.; Muller C.P., 1988: Platelet and vessel associated prostacyclin and thromboxane a 2 prostaglandin endoperoxide receptors

Siebers M.J.; Goodfriend T.L., 1986: Platelet angiotensin receptors in young and old humans

Masel B.E.; Chesson A.L.; Peters B.H.; Levin H.S.; Alperin J.B., 1980: Platelet antagonists in migraine prophylaxis a clinical trial using aspirin and dipyridamole

Mimura T.; Kohama Y.; Kuwahara S.; Yamamoto K.; Komiyama Y.; Satake M.; Chiba Y.; Miyashita K.; Tanaka T.; Et Al, 1988: Platelet anti aggregant activity of 2 2 dimethylthiazolidine hydrochloride and 2 4 hydroxy 3 methoxyphenylthiazolidine

Gomez M.L.; Botella F.G.; Simo M.R.; Martinez J.V.B.; Candel V.A., 1984: Platelet anti aggregants in the treatment of cerebral ischemic accidents

Yun Choi H.S.; Paik S.W.; Lee J.R., 1986: Platelet anti aggregating activities of higenamine analogs

Canestrini, C.; Testa, R., 1978: Platelet anti aggregating activity of alclofenac a preliminary pharmacodynamic and kinetic study in rabbit

Garcia-Conde, J.; Merino, J.; Golpe, J. A.; Benet, I., 1976: Platelet anti aggregating activity of furosemide

Tremoli E.; Maderna P.; Cocuzza E.; Mantero O., 1979: Platelet anti aggregating activity of imolamine in vitro studies

Avellone G.; Mandala V.; Novo S.; Pinto A.; Riolo F.P.; Davi G.; Raneli G., 1981: Platelet anti coagulant drugs and ischemic cardiopathy evaluation of the effect on platelet coagulation and anti thrombin iii

Weir, E. K.; Mlczoch, J.; Seavy, J.; Cohen, J. J.; Grover, R. F., 1976: Platelet anti serum inhibits hypoxic pulmonary vaso constriction in the dog

Czapek E.E.; Kwaan H.C., 1980: Platelet anti thrombin activity

Tullis, J. L.; Watanabe, K., 1978: Platelet anti thrombin deficiency a new clinical entity

Watanabe, K.; Chao, F. C.; Tullis, J. L., 1977: Platelet anti thrombins role of thrombin binding and the release of platelet fibrinogen

De La Cruz J.P.; Pavia J.; Bellido I.; Gonzalez M.C.; Sanchez De La Cuesta F., 1988: Platelet antiaggregatory effect of triflusal in human whole blood

Ioannou P.; Talesnik J., 1986: Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction

Gandolfo, G. M.; Afeltra, A.; Amendolea, M. A.; Mannella, E.; Masala, C., 1977: Platelet antibodies in different forms of chronic thrombocytopenia

Veenhoven W.A.; Van Der Schans G.S.; Nieweg H.O., 1980: Platelet antibodies in idiopathic thrombocytopenic purpura

Brink S.; Hesseling P.B.; Amadhila S.; Visser H.S., 1981: Platelet antibodies in immune thrombocytopenic purpura and onyalai

Wautier J.L.; Boizard B.; Patereau C.; Muller J.Y., 1982: Platelet antibodies in patients with thrombocytopenic purpura studied by 2 techniques

Kaplan C.; Champeix P.; Blanchard D.; Muller J.Y.; Cartron J.P., 1987: Platelet antibodies in systemic lupus erythematosus

Hegde, U. M.; Gordon-Smith, E. C.; Worlledge, S., 1977: Platelet antibodies in thrombocytopenic patients

Hasdal O.; Ozsoylu S.; Kocak N., 1987: Platelet antibodies in viral hepatitis

Cines D.B.; Wilson S.B.; Tomaski A.; Schreiber A.D., 1985: Platelet antibodies of the immunoglobulin m class in immune thrombocytopenic purpura

Howe S.E.; Lynch D.M., 1987: Platelet antibody binding in systemic lupus erythematosus

Leone, G.; Breda, M.; Accorra, F.; Bizzi, B., 1978: Platelet antibody determination by platelet factor 3 assay comparison with radio labeled serotonin release and platelet aggregometry

Dixon, R. H.; Rosse, W. F., 1975: Platelet antibody in auto immune thrombocytopenia

Sugiura K.; Steiner M.; Baldini M.G., 1980: Platelet antibody in idiopathic thrombocytopenic purpura and other thrombocytopenias a quantitative sensitive and rapid assay

Ware R.; Kinney T.R.; Rosse W., 1985: Platelet antibody in prolonged remission of childhood idiopathic thrombocytopenic purpura

Kernoff L.M.; Malan E., 1983: Platelet antibody levels do not correlate with response to therapy in idiopathic thrombocytopenic purpura

Mason D.; Mcmillan R., 1984: Platelet antigens in chronic idiopathic thrombocytopenic purpura

Belotskii, S. M., 1976: Platelet antigens in dogs

Sloand E.M.; Kenney D.M.; Chao F.C.; Lawler J.; Tullis J.L., 1987: Platelet antithrombin defect in malignancy platelet protein alterations

Gordon P.R.; Browning J.D.; O'dell B.L., 1983: Platelet arachidonate metabolism and platelet function in zinc deficient rats

Jubelirer S.J.; Russell F.; Vaillancourt R.; Deykin D., 1980: Platelet arachidonic acid metabolism and platelet function in 10 patients with chronic myelogenous leukemia

Sie P.; Perret B.; Cousin F.; Mauco G.; Boneu B.; Chap H.J.; Rascol A.; Douste Blazy L., 1982: Platelet arachidonic acid metabolism in severe cerebro vascular disease

Mcmillian R.; Tani P.; Millard F.; Berchtold P.; Renshaw L.; Woods V.L.Jr, 1987: Platelet associated and plasma anti glycoprotein autoantibodies in chronic itp

Giddings, J. C.; Shearn, S. A. M.; Bloom, A. L., 1978: Platelet associated coagulation factors immunological detection and the effect of calcium

Myers T.J.; Kim B.K.; Steiner M.; Baldini M.G., 1982: Platelet associated complement c 3 in immune thrombocytopenic purpura

Kayser W.; Mueller Eckhardt C.; Bhakdi S.; Ebert K., 1983: Platelet associated complement c 3 in thrombocytopenic states

Hegde U.M.; Bowes A.; Roter B.L.T., 1985: Platelet associated complement components pac 3c and pac 3d in patients with autoimmune thrombocytopenia

Kurata Y.; Curd J.G.; Tamerius J.D.; Mcmillan R., 1985: Platelet associated complement in chronic immune thrombocytopenic purpura

Frampton G.; Perl S.; Bennett A.; Cameron J.S., 1986: Platelet associated dna and anti dna antibody in systemic lupus erythematosus with nephritis

Vos J.J.E.; Huisman J.G.; Van Der Lelie J.; Von Dem Borne A.E.G.K., 1987: Platelet associated igg in thrombocytopenia a comparison of two techniques

Fujisawa J.; Akatsuka J I., 1987: Platelet associated igg on high dose intravenous immunoglobulin for idiopathic thrombocytopenic purpura

Nieminen U.; Syrjala M.; Ikkala E.; Myllyla G., 1988: Platelet associated igg platelet mean life span and treatment with intravenous immunoglobulin in idiopathic thrombocytopenic purpura

Wautier J.L.; Boizard B.; Wautier M.P.; Kadeva H.; Caen J.P., 1980: Platelet associated immuno globulin g and circulating immune complexes in thrombocytopenic purpura

Hasselbalch H.; Berild D.; Hansen O.P., 1984: Platelet associated immuno globulin g and immuno globulin m in myelo fibrosis

Landolei R.; Leone G.; Fedelti G.; Storti S.; Laghi F.; Bizzi B., 1980: Platelet associated immuno globulin g in acute and chronic hepatic diseases

Cheung N K.V.; Hilgartner M.W.; Schulman I.; Mcfall P.; Glader B.E., 1983: Platelet associated immuno globulin g in childhood idiopathic thrombocytopenic purpura

Lightsey A.L.Jr; Koenig H.M.; Mcmillan R.; Stone J.R.Jr, 1979: Platelet associated immuno globulin g in childhood idiopathic thrombocytopenic purpura

Graber D.; Giuliani D.; Leevy C.M.; Morse B.S., 1984: Platelet associated immuno globulin g in hepatitis and cirrhosis

Luiken, G. A.; Mcmillan, R.; Lightsey, A. L.; Gordon, P.; Zevely, S.; Schulman, I.; Gribble, T. J.; Longmire, R. L., 1977: Platelet associated immuno globulin g in immune thrombocytopenic purpura

Berkman A.W.; Kickler T.; Braine H., 1984: Platelet associated immuno globulin g in patients with lymphoma

Thomsen S.; Giuliani D.; Chang D.; Lasker N.; Morse B.S., 1983: Platelet associated immuno globulin g in uremia

Mueller Eckhardt C.; Mueller Eckhardt G.; Kayser W.; Voss R.M.; Wegner J.; Kueenzlen E., 1982: Platelet associated immuno globulin g platelet survival and platelet sequestration in thrombocytopenic states

Pawha J.; Giuliani D.; Morse B.S., 1983: Platelet associated immuno globulin m levels in thrombocytopenia

Winiarski J.; Holm G., 1983: Platelet associated immuno globulins and complement in idiopathic thrombocytopenic purpura

Lazarchick J.; Hall S.A., 1986: Platelet associated immunoglobulin g assay using flow cytometric analysis

Ljung R.; Nilsson I.M.; Frohm B.; Holmberg L., 1986: Platelet associated immunoglobulin g in childhood idiopathic thrombocytopenic purpura measurements on intact and solubilized platelets and after gamma globulin treatment

Fujisawa K.; Akatsuka J I., 1985: Platelet associated immunoglobulin g in children values and evaluation of platelet associated immunoglobulin g in various thrombocytopenias

Bennett A.; Frampton G.; Cameron J.S., 1986: Platelet associated immunoglobulin g in idiopathic glomerulonephritis and the nephritis of systemic lupus erythematosus

Steiner M., 1985: Platelet associated immunoglobulin g is a specific protein

Corash L.; Shafer B.; Blaese R.M., 1985: Platelet associated immunoglobulin platelet size and the effect of splenectomy in the wiskott aldrich syndrome

Pfueller S.L.; David R., 1988: Platelet associated immunoglobulins g a and m are secreted during platelet activation normal levels but defective secretion in gray platelet syndrome

Panzer S.; Szamait S.; Boedeker R H.; Haas O.A.; Haubenstock A.; Mueller Eckhardt C., 1986: Platelet associated immunoglobulins immunoglobulin g immunoglobulin m immunoglobulin a and complement c 3 in immune and nonimmune thrombocytopenic disorders

Panzer S.; Niessner H.; Lechner K.; Dudczak R.; Jaeger U.; Mayr W.R., 1986: Platelet associated immunoglobulins immunoglobulin g immunoglobulin m immunoglobulin a and complement c 3c in chronic idiopathic autoimmune thrombocytopenia relation to the sequestration pattern of indium 111 labeled platelets

Hegde U.M.; Ball S.; Zuiable A.; Roter B.L.T., 1985: Platelet associated immunoglobulins in autoimmune thrombocytopenia

Bassendine M.F.; Collins J.D.; Stephenson J.; Saunders F.; James O.F.W., 1985: Platelet associated immunoglobulins in primary biliary cirrhosis a cause of thrombocytopenia?

Miller W.R.; Dawes J., 1985: Platelet associated proteins in human breast cyst fluids

Grinnell F.; Phan T.V., 1985: Platelet attachment and spreading on polystyrene surfaces dependence on fibronectin and plasma concentration

Knauer K.A.; Kagey Sobotka A.; Adkinson N.F.Jr; Lichtenstein L.M., 1984: Platelet augmentation of immuno globulin e dependent histamine release from human basophils and mast cells

Chanarin, I.; James, D.; Stafford, D.; Tidmarsh, E., 1977: Platelet auto immunity

Van Der Lelie J.; Van Der Plas Van Dalen C.M.; Von Dem Borne A.E.G.K., 1984: Platelet autoantibodies in septicemia

Han S.; Et Al, 1986: Platelet autoantibody detection with immunofluorescence test in idiopathic thrombocytopenic purpura in children

De Jong J.C.F.; Sibinga C.T.S.; Wildevuur C.R.H., 1979: Platelet behavior in extracorporeal circulation

Peacock I.; Hawkins M.; Heptinstall S., 1986: Platelet behavior in non insulin dependent diabetes influence of vascular complications treatment and metabolic control

Morrison R.; Crawford J.; Macpherson M.; Heptinstall S., 1985: Platelet behavior in normal pregnancy pregnancy complicated by essential hypertension and pregnancy induced hypertension

D'andrea G.; Toldo M.; Cananzi A.; Cortelazzo S.; Ferro Milone F., 1985: Platelet behavior in patients with transient ischemic attack responsiveness to small doses of aspirin

Kerry R.; Scrutton M.C., 1983: Platelet beta adrenoceptors

Santos M.T.; Valles J.; Aznar J.; Villa P., 1982: Platelet beta thrombo globulin release in vitro induced by mechanical and chemical stimulus correlation with the aggregation curve parameters

Rote, N. S.; Lau, R. J.; Harrison, M. R.; Branch, D. W.; Scott, J. R., 1987: Platelet binding immunoglobulins in pregnancy induced hypertension i. platelet associated igm on fetal platelets evidence of a fetal autoimmune reaction

Rote, N. S.; Harrison, M. R.; Scott, J. R., 1987: Platelet binding immunoglobulins in pregnancy induced hypertension ii. origin of circulating igg and igm antiplatelet antibodies in the umbilical cord serum

Williams W.R.; Cavolina F.; Williams W.J., 1983: Platelet binding in mononuclear cell preparations from peripheral blood

Green, D.; Muller, H. P., 1978: Platelet binding of the von willebrand factor

Asano T.; Furie B.C.; Furie B., 1985: Platelet binding properties of monoclonal lupus autoantibodies produced by human hybridomas

Nutt D.J.; Fraser S., 1987: Platelet binding studies in panic disorder

Dumont A.E.; Robbins E.; Martelli A.; Iliescu H., 1981: Platelet blockade of particle absorption from the peritoneal surface of the diaphragm

Hauch, T. W.; Rosse, W. F., 1977: Platelet bound complement c 3 in immune thrombocytopenia

Mulshine J.; Lucas F.V.; Clough J.D., 1981: Platelet bound immuno globulin g in systemic lupus erythematosus with and without thrombocytopenia

Nel J.D.; Stevens K.; Mouton A.; Pretorius F.J., 1983: Platelet bound immuno globulin m in auto immune thrombocytopenia

Bonacossa I.A.; Chalmers I.M.; Rayner H.L.; Hunter T., 1985: Platelet bound immunoglobulin g levels in patients with systemic lupus erythematosus

Green, D.; Potter, E. V., 1976: Platelet bound ristocetin aggregation factor in normal subjects and patients with von willebrands disease

Tapley P.M.; Murray A.W., 1984: Platelet calcium activated phospho lipid dependent protein kinase evidence for proteolytic activation of the enzyme in cells treated with phospho lipase c 1

Men'shikov M.Yu; Avdonin P.V.; Negresku E.V.; Bugrii E.M.; Svitina Ulitina I.V.; Ratner E.I.; Mazaev A.V.; Tkachuk V.A., 1986: Platelet calcium channel blockade by cardiotropic compounds

White G.C.II; Levine S.N.; Steiner A.N., 1981: Platelet calcium dependent proteins identification and localization of the calcium dependent regulator calmodulin in platelets

Rengasamy A.; Soura S.; Feinberg H., 1987: Platelet calcium homeostasis sodium calcium exchange in plasma membrane vesicles

Gastpar, H., 1977: Platelet cancer cell interaction in metastasis formation a possible therapeutic approach to metastasis prophylaxis

Kimura A.; Fujimura K.; Kuramoto A., 1987: Platelet catalase glutathione peroxidase and superoxide dismutase in patients with myeloproliferative disorders

Wilson A.P.; Smith C.C.T.; Prichard B.N.C.; Betteridge D.J., 1987: Platelet catecholamines and platelet function in normal human subjects

Belch J.J.F.; Saniabadi A.R.; Mclaughlin K.; Forbes C.D., 1987: Platelet changes after a saturated fat meal and their prevention by dazmegrel a thromboxane synthetase inhibitor

Clagett, G. P.; Russo, M.; Hufnagel, H., 1981: Platelet changes after placement of aortic prostheses in dogs 1. biochemical and functional alterations

Clagett, G. P.; Russo, M.; Hufnagel, H., 1981: Platelet changes after placement of aortic prostheses in dogs 2. impaired surface induced arterial thrombosis

Norberg B.; Nilsson T.K., 1987: Platelet clumping in ph negative myeloproliferative syndromes

Walsh, P. N.; Goldberg, R. E.; Tax, R. L.; Magargal, L. E., 1977: Platelet coagulant activities and retinal vein thrombosis

Walsh, P. N.; Pareti, F. I.; Corbett, J. J., 1976: Platelet coagulant activities and serum lipids in transient cerebral ischemia

Walsh P.N.; Kansu T.; Savino P.J.; Schatz N.J.; Magargal L.E.; Goldberg R.E.; Corbett J.J., 1979: Platelet coagulant activities in arterial occlusive disease of the eye

Rao A.K.; Goldberg R.E.; Walsh P.N., 1984: Platelet coagulant activities in diabetes mellitus evidence for relationship between platelet hyper activity and platelet volume

Laduca F.M.; Bell W.R.; Bettigole R.E., 1987: Platelet collagen adhesion enhances platelet aggregation induced by binding of vwf to platelets

Shadle P.J.; Barondes S.H., 1984: Platelet collagen adhesion evidence for participation of antigenically distinct entities

Shadle P.J.; Ginsberg M.; Plow E.F.; Barondes S.H., 1984: Platelet collagen adhesion inhibition by a monoclonal antibody that binds glycoprotein iib

Fauvel, F.; Legrand, Y. J.; Bentz, H.; Fietzek, P. P.; Kuhn, K.; Caen, J. P., 1978: Platelet collagen interaction adhesion of human blood platelets to purified cb 4 peptide from type iii collagen

Chiang T.M.; Jin A.; Kang A.H., 1987: Platelet collagen interaction inhibition by a monoclonal antibody raised against collagen receptor

Laduca F.M.; Bettigole R.E.; Bell W.R.; Robson E.B., 1986: Platelet collagen interaction inhibition by ristocetin and enhancement by von willebrand factor platelet binding

Balleisen, L.; Marx, R.; Kuehn, K., 1976: Platelet collagen interaction the influence of native and modified collagen type i on the aggregation of human platelets

Aihara M.; Cooper H.A.; Wagner R.H., 1984: Platelet collagen interactions increase in rate of adhesion of fixed washed platelets by factor viii related antigen

Katz A.J.; Genco P.V.; Blumberg N.; Snyder E.L.; Camp B.; Morse E.E., 1981: Platelet collection and transfusion using the fenwal cs 3000 cell separator

Tandy N.P.; Taylor M.A., 1980: Platelet concentrates for transfusion control of production and storage

Snyder E.L.; Koerner T.A.W.Jr; Hezzey A., 1982: Platelet concentrates influence of different preparative protocols on the in vitro release reaction

Oiestad W.; Nygaard E.B.; Juel E.O., 1986: Platelet concentrates made from the buffy coat

Wallvik J.; Akerblom O., 1983: Platelet concentrates stored at 22 celsius need oxygen the significance of plastics in platelet preservation

Pietersz R.N.I.; Loos J.A.; Reesink H.W., 1985: Platelet concentrates stored in plasma for 72 hours at 22 celsius prepared from buffy coats of citrate phosphate dextrose blood collected in a quadruple bag saline adenine glucose mannitol system

Kawada T.; Funaki S.; Hoson M.; Masaki H.; Ando N.; Osada H.; Okada T.; Hiekata T.; Noguchi T., 1986: Platelet consumption and its prevention during cardiopulmonary bypass with membrane oxygenator

Gjesdal, K.; Abrahamsen, A. F., 1976: Platelet consumption and plasma concentration of platelet factor 4

Schneider R.C.; Zapol W.M.; Carvalho A.C., 1980: Platelet consumption and sequestration in severe acute respiratory failure

Harker, L. A.; Slichter, S. J.; Sauvage, L. R., 1977: Platelet consumption by arterial prostheses the effects of endothelialization and pharmacologic inhibition of platelet function

Alekseeva L.M., 1980: Platelet contractile proteins in normal conditions and in experimental aortic thrombosis

Poggi A.; Vicenzi E.; Cioce V.; Wasteson A., 1988: Platelet contribution to cancer cell growth and migration the role of platelet growth factors

Bastida E.; Ordinas A., 1988: Platelet contribution to the formation of metastatic foci the role of cancer cell induced platelet activation

Sharma S.C., 1982: Platelet count and adhesiveness on induction to high altitude by air and road

Endresen, G. K. M.; Hoyeraal, H. M.; Kaas, E., 1977: Platelet count and disease activity in juvenile rheumatoid arthritis

Porro F.; Martinotti R.; Delu A.; Sardella F.; Fanelli M.; Pierini A.; Pastori P., 1983: Platelet count and platelet function in patients with angina pectoris before and after a cyclo ergometric exercise test

Bain B.J., 1985: Platelet count and platelet size in males and females

Gafter U.; Bessler H.; Malachi T.; Zevin D.; Djaldetti M.; Levi J., 1987: Platelet count and thrombopoietic activity in patients with chronic renal failure

Sharma S.C., 1981: Platelet count in permanent residents of high altitude

Sharma S.C., 1980: Platelet count in temporary residents of high altitude

Milner P.C.; Johl S.; Martin J.F., 1987: Platelet count is positively correlated with white cell count and red cell count

Sharma S.C., 1980: Platelet count on acute induction to high altitude

Sharma S.C., 1986: Platelet count on slow induction to high altitude

Chatterji J.C.; Ohri V.C.; Das B.K.; Chadha K.S.; Akhtar M.; Bhatacharji P.; Tewari S.C.; Behl A., 1982: Platelet count platelet aggregation and fibrinogen levels following acute induction to high altitude 3200 and 3771 meters

Benner K.U.; Tamblyn C.H.; Swank R.L.; Seaman G.V.F., 1980: Platelet count ratio as an additional parameter in the quantitation of platelet aggregation in vitro

Azikiwe A.N., 1984: Platelet count values in healthy nigerian medical students in jos nigeria

Guthrie D.L.; Campbell S.R.; Maidment N.J.M., 1981: Platelet counting errors with the coulter counter model s plus

Joller P.W.; Babo C.; Hitzig W.H., 1982: Platelet counting in a medium size routine clinical laboratory

Heinemann G.; Guenner H., 1980: Platelet counting in whole blood by means of a new counter with hydrodynamic focused aperture

Giannitsis D.J., 1979: Platelet counting with a laser nephelometer

Noe D.A.; Graham S.M.; Luff R.; Sohmer P., 1982: Platelet counts during rapid massive transfusion

Yasui M.; Kim T.; Taniguchi A.; Kanki H.; Tani K.; Takeuchi Y.; Kamitsuji H.; Iwagaki K., 1979: Platelet counts fibrinogen factor viii complex and factor xiii in muco cutaneous lymph node syndrome

Twardowski Z.; Dmoszynska A.; Janicka L.; Gutka A.; Kowalewski J., 1982: Platelet counts in blood taken from femoral artery femoral vein cubital vein and arterio venous fistula

Feusner J.H.; Behrens J.A.; Detter J.C.; Cullen T.C., 1979: Platelet counts in capillary blood

Ogala, W. N., 1986: Platelet counts in health nigerian neonates and infants

Effiong, C. E.; Usanga, E. A.; Mellits, E. D., 1976: Platelet counts in healthy full term nigerian neo nates

Fagher B.; Sjogren A.; Sjogren U., 1985: Platelet counts in myocardial infarction angina pectoris and peripheral artery disease

Mukiibi J.M.; Okelo G.B.A.; Kanja C., 1981: Platelet counts in normal kenyan adults

Saxena S.; Cramer A.D.; Weiner J.M.; Carmel R., 1987: Platelet counts in three racial groups

Yam P.; Petz L.D.; Scott E.P.; Santos S., 1984: Platelet cross match tests using radio labeled staphylococcal protein a or peroxidase anti peroxidase in allo immunized patients

Kieckbusch M.E.; Moore S.B.; Koenig V.A.; Degoey S.R., 1987: Platelet crossmatch evaluation in refractory hematologic patients

Kickler T.S.; Ness P.M.; Braine H.G., 1988: Platelet crossmatching a direct approach to the selection of platelet transfusion for the alloimmunized thrombocytopenic patient

Shepherd, K. M.; Sage, R. E.; Barber, S.; O'brien, E., 1984: Platelet cryo preservation 1. in vitro aggregation studies

Hicking D.R.; Olsen R.E., 1980: Platelet cryo preservation a simple routine

Brothagen U.A.; Armitage W.J.; Parmar N., 1985: Platelet cryopreservation with glycerol dextran and mannitol recovery of 5 hydroxytryptamine uptake and hypotonic stress response

Hidaka, H.; Asano, T., 1976: Platelet cyclic 3 5 nucleotide phospho di esterase released by thrombin and calcium ionophore

Nakanishi K.; Ikeda K.; Imai A.; Hato T.; Kaneko H.; Murakami A.; Kuwashima K.; Kaido H.; Kondo M.; Et Al, 1984: Platelet cyclo oxygenase deficiency in a japanese

Cinti, D. L.; Feinstein, M. B., 1976: Platelet cytochrome p 450 a possible role in arachidonate induced aggregation

Kometani M.; Sato T.; Fujii T., 1986: Platelet cytoskeletal components involved in shape change and secretion

Jung S.M.; Moroi M., 1988: Platelet cytoskeletal protein distributions in two triton insoluble fractions and how they are affected by stimulants and reagents that modify cytoskeletal protein interactions

Puszin E.G.; Jenkins C.S.P.; Ores Carton C.; Zucker M.B., 1985: Platelet cytoskeleton alpha actinin in normal and thrombasthenic platelets distribution and immunologic characterization

Billett H.H.; Jenkins C.S.P.; Maimon J.; Spaet T.H.; Puszkin E.G., 1984: Platelet cytoskeleton immunofluorescence studies on adp and collagen activated platelets

Jenkins C.S.P.; Maimon J.; Puszkin E.G., 1984: Platelet cytoskeleton immunofluorescence studies on thrombin activated platelets

Wu M P.; Stracher A., 1985: Platelet cytoskeleton membrane interactions

Vedia L.M.M.Y.; Reep B.R.; Lapetina E.G., 1988: Platelet cytosolic 44 kda protein is a substrate of a cholera toxin induced adp ribosylation and is not recognized by antisera against the alpha subunit of the stimulatory guanine nucleotide binding regulatory protein

Boonstra P.W.; Vermeulen F.E.E.; Leusink J.A.; De Nooy E.H.; Van Zalk A.; Soons J.B.J.; Wildevuur C.R.H., 1987: Platelet damage and hemolysis during bubble oxygenator perfusion with and without arterial line filter compared to membrane oxygenator perfusion

Velders A.J.; Wildevuur R.H., 1986: Platelet damage by protamine and the protective effect of prostacyclin an experimental study in dogs

Grinshtein Yu I.; Kalinina I.A.; Vitman T.V., 1986: Platelet deformity in patients with acute and chronic renal failure

Hourdille P.; Bernard P.; Broustet A.; Boisseau M.R.; Reiffers J., 1980: Platelet dense bodies loaded with mepacrine study in chronic idiopathic thrombocytopenic purpura

Boneu B.; Sie P.; Eche N.; Caranobe C., 1983: Platelet density analysis a tool for the detection of acquired storage pool disease in man

Penington, D. G.; Lee, N. L. Y.; Roxburgh, A. E.; Mcgready, J. R., 1976: Platelet density and size the interpretation of heterogeneity

Parker R.I.; Shafer B.C.; Gralnick H.R., 1987: Platelet density dependent partition of platelet von willebrand factor between alpha granule and non alpha granule pools

Weksler, B. B.; Coupal, C. E., 1973: Platelet dependent generation of chemo tactic activity in serum

Laghi Pasini F.; Ceccatelli L.; Pasqui A.L.; Orrico A.; Capecchi P.L.; Di Perri T., 1985: Platelet dependent granulocyte activation in vitro effect of ticlopidine

Coughlin S.R.; Moskowitz M.A.; Zetter B.R.; Antoniades H.N.; Levine L., 1980: Platelet dependent stimulation of prostacyclin synthesis by platelet derived growth factor

Mullane K.M.; Mcgiff J.C., 1985: Platelet depletion and infarct size in an occlusion reperfusion model of myocardial ischemia in anesthetized dogs

Jolly S.R.; Schumacher W.A.; Kunkel S.L.; Abrams G.D.; Liddicoat J.; Lucchesi B.R., 1985: Platelet depletion in experimental myocardial infarction

Feinberg H.; Rosenbaum D.S.; Levitsky S.; Silverman N.A.; Kohler J.; Lebreton G., 1982: Platelet deposition after surgically induced myo cardial ischemia an etiologic factor for re perfusion injury

Minar, E.; Ehringer, H.; Ahmadi, R.; Dudczak, R.; Porenta, G., 1987: Platelet deposition at angioplasty sites and platelet survival time after pta in iliac and femoral arteries investigations with indium 111 oxine labelled platelets in patients with asa 1.0 g day therapy

Stratton J.R.; Zierler E.; Kazmers A., 1987: Platelet deposition at carotid endarterectomy sites in humans

Poot A.; Beugeling T.; Cazenave J.P.; Bantjes A.; Van Aken W.G., 1988: Platelet deposition in a capillary perfusion model quantitative and morphological aspects

Foegh M.L.; Khirabadi B.S.; Ramwell P.W., 1986: Platelet deposition in rat heart allografts and the effect of a thromboxane receptor antagonist

Stratton J.R.; Thiele B.L.; Ritchie J.L., 1982: Platelet deposition on dacron aortic bifurcation grafts in man quantitation with indium 111 platelet imaging

Sinzinger H.; O'grady J.; Fitscha P., 1988: Platelet deposition on human atherosclerotic lesions is decreased by low dose aspirin in combination with dipyridamole

Badimon, L.; Badimon, J. J.; Rand, J.; Turitto, V. T.; Fuster, V., 1987: Platelet deposition on von willebrand factor deficient vessels extracorporeal perfusion studies in swine with von willebrand's disease using native and heparinized blood

Chiu Y.L.; Chou Y.L.; Jen C.J., 1988: Platelet deposition onto fibrin coated surfaces under flow conditions

Tavassoli, M.; Yelenosky, R., 1977: Platelet derived acid phosphatase iso enzyme in the serum in thrombocythemia

Cooper T.W.; Eisen A.Z.; Stricklin G.P.; Welgus H.G., 1985: Platelet derived collagenase inhibitor characterization and subcellular localization

Hunziker T.; Nydegger U.E.; Lerch P.G.; Vassalli J D., 1986: Platelet derived factors enhance pemphigus acantholysis in skin organ cultures

Raines, E. W.; Ross, R., 1982: Platelet derived growth factor 1. high yield purification and evidence for multiple forms

Bowen-Pope, D. F.; Ross, R., 1982: Platelet derived growth factor 2. specific binding to cultured cells

Glenn, K.; Bowen-Pope, D. F.; Ross, R., 1982: Platelet derived growth factor 3. identification of a platelet derived growth factor receptor by affinity labeling

Bonthron, D. T.; Morton, C. C.; Orkin, S. H.; Collins, T., 1988: Platelet derived growth factor a chain gene structure chromosomal location and basis for alternative messenger rna splicing

Mercola M.; Melton D.A.; Stiles C.D., 1988: Platelet derived growth factor a chain is maternally encoded in xenopus embryos

Johnsson A.; Betsholtz C.; Von Der Helm K.; Heldin C H.; Westermark B., 1985: Platelet derived growth factor agonist activity of a secreted form of the v sis oncogene product

Zulllo J.N.; Cochran B.H.; Huang A.S.; Stiles C.D., 1985: Platelet derived growth factor and double stranded rna stimulate expression of the same genes in 3t3 cells

Majack, R. A.; Cook, S. C.; Bornstein, P., 1985: Platelet derived growth factor and heparin like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells

Hill D.J.; Milner R.D.G., 1984: Platelet derived growth factor and multiplication stimulating activity ii but not multiplication stimulating activity iii 2 stimulate tritium labeled thymidine and sulfur 35 labeled sulfate incorporation by fetal rat costal cartilage in vitro

Hiyama Y.; Mahmud I.; Karimi Tari F.; Fujita S.; Fukui N.; Miura Y., 1981: Platelet derived growth factor and thromboxane are necessary for liver regeneration

Williams L.T.; Tremble P.; Antoniades H.N., 1982: Platelet derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable

Callahan K.S.; Schorer A.; Harlan J.M., 1986: Platelet derived growth factor does not stimulate prostacyclin synthesis by cultured endothelial cells

Rozengurt E.; Stroobant P.; Waterfield M.D.; Deuel T.F.; Keehan M., 1983: Platelet derived growth factor elicits cyclic amp accumulation in swiss 3t3 cells role of prostaglandin production

Howes R.; Bowness J.M.; Grotendorst G.R.; Martin G.R.; Reddi A.H., 1988: Platelet derived growth factor enhances demineralized bone matrix induced cartilage and bone formation

Mondschein J.S.; Schomberg D.W., 1981: Platelet derived growth factor enhances granulosa cell luteinizing hormone receptor induction by follicle stimulating hormone and serum

Delwiche F.; Raines E.; Powell J.; Ross R.; Adamson J., 1985: Platelet derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells

Inglot A.D.; Inglot O., 1981: Platelet derived growth factor enhances the growth of moloney sarcoma virus induced tumors in mice

Barrett T.B.; Benditt E.P., 1988: Platelet derived growth factor gene expression in human atherosclerotic plaques and normal artery wall

Johnsson A.; Heldin C H.; Wasteson A.; Westermark B., 1982: Platelet derived growth factor identification of constituent poly peptide chains

Bowen Pope D.F.; Malpass T.W.; Foster D.M.; Ross R., 1984: Platelet derived growth factor in vivo levels activity and rate of clearance

Shupnik M.A.; Antoniades H.N.; Tashjian A.H.Jr, 1982: Platelet derived growth factor increase prostaglandin production and decreases epidermal growth factor receptors in human osteo sarcoma cells

Herman B.; Pledger W.J., 1985: Platelet derived growth factor induced alterations in vinculin and actin distribution in balb c 3t3 cells

Herman B.; Roe M.W.; Harris C.; Wray B.; Clemmons D., 1987: Platelet derived growth factor induced alterations in vinculin distribution in porcine vascular smooth muscle cells

Frick K.K.; Womer R.B.; Scher C.D., 1988: Platelet derived growth factor induced c myc rna expression analysis of an inducible pathway independent of protein kinase c

Gould K.L.; Hunter T., 1988: Platelet derived growth factor induced multisite phosphorylation of pp60c s r c and increases its protein tyrosine kinase activity

Sturani E.; Vicentini L.M.; Zippel R.; Toschi L.; Pandiella Alonso A.; Comoglio P.M.; Meldolesi J., 1986: Platelet derived growth factor induced receptor phosphorylation and phosphoinositide hydrolysis are unaffected by protein kinase c activation in mouse swiss 3t3 and human skin fibroblasts

Vicenzi E.; Bianchi M.; Salmona M.; Donati M.B.; Poggi A.; Ghezzi P., 1985: Platelet derived growth factor induces ornithine decarboxylase activity in nih 3t3 cells

Kruijer W.; Cooper J.A.; Hunter T.; Verma I.M., 1984: Platelet derived growth factor induces rapid but transient expression of the c fos gene and protein

Hall D.J.; Stiles C.D., 1987: Platelet derived growth factor inducible genes respond differentially to at least two distinct intracellular second messengers

Oleszak E.; Inglot A.D., 1980: Platelet derived growth factor inhibits anti viral and anti cellular action of interferon in synchronized mouse or human cells

Chudzio T.S.; Inglot A.D., 1980: Platelet derived growth factor inhibits priming in synchronous mouse or human fibroblasts producing interferon

Grotendorst G.R.; Chang T.; Seppa H.E.J.; Kleinman H.K.; Martin G.R., 1982: Platelet derived growth factor is a chemo attractant for vascular smooth muscle cells

Besnard F.; Perraud F.; Sensenbrenner M.; Labourdette G., 1987: Platelet derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro

Seppa H.; Grotendorst G.; Seppa S.; Schiffman E.; Martin G.R., 1982: Platelet derived growth factor is chemo tactic for fibroblasts

Campochiaro P.A.; Glaser B.M., 1985: Platelet derived growth factor is chemotactic for human retinal pigment epithelial cells

Katoh O.; Kimura A.; Kuramoto A., 1988: Platelet derived growth factor is decreased in patients with myeloproliferative disorders

Marez A.; N'guyen T.; Chevallier B.; Clement G.; Dauchel M.C.; Barritault D., 1987: Platelet derived growth factor is present in human placenta purification from an industrially processed fraction

Heldin C H.; Westermark B.; Wasteson A., 1981: Platelet derived growth factor isolation by a large scale procedure and analysis of subunit composition

Handley D.A.; Witte L.D., 1984: Platelet derived growth factor labeled to colloidal gold for use as a mitogenic receptor probe

Davis R.J.; Czech M.P., 1985: Platelet derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine 654

Bryckaert M.C.; Rendu F.; Tobelem G.; Caen J., 1986: Platelet derived growth factor modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets

Pledger W.J.; Hart C.A.; Locatell K.L.; Scher C.D., 1981: Platelet derived growth factor modulated proteins constitutive synthesis by a transformed cell line

Hendrickson S.L.; Scher C.D., 1983: Platelet derived growth factor modulated translatable messenger rna

Olashaw N.E.; O'keefe E.J.; Pledger W.J., 1986: Platelet derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters

Rosenfeld M.E.; Bowen Pope D.F.; Ross R., 1984: Platelet derived growth factor morphologic and biochemical studies of binding internalization and degradation

Tzeng D.Y.; Deuel T.F.; Huang J.S.; Baehner R.L., 1985: Platelet derived growth factor promotes human peripheral monocyte activation

Tzeng D.Y.; Deuel T.F.; Huang J.S.; Senior R.M.; Boxer L.A.; Baehner R.L., 1984: Platelet derived growth factor promotes polymorphonuclear leukocyte activation

Dainiak N.; Davies G.; Kalmanti M.; Lawler J.; Kulkarni V., 1983: Platelet derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro

Heldin C H.; Westermark B.; Wasteson A., 1979: Platelet derived growth factor purification and partial characterization

Escobedo J.A.; Keating M.T.; Ives H.E.; Williams L.T., 1988: Platelet derived growth factor receptors expressed by complementary dna transfection couple to a diverse group of cellular responses associated with cell proliferation

Williams L.T.; Tremble P.M.; Lavin M.F.; Sunday M.E., 1984: Platelet derived growth factor receptors form a high affinity state in membrane preparations kinetics and affinity cross linking studies

Currie G.A., 1981: Platelet derived growth factor requirements for in vitro proliferation of normal and malignant mesenchymal cells

Sullivan N.J.; Tashjian A.H.Jr, 1983: Platelet derived growth factor selectively decreases prolactin production in pituitary cells in culture

Huang J.S.; Huang S.S.; Deuel T.F.; Kennedy B., 1982: Platelet derived growth factor specific binding to target cells

Harrington M.A.; Pledger W.J., 1987: Platelet derived growth factor stimulated mechanisms of glucosamine incorporation

Chait A.; Ross R.; Albers J.J.; Bierman E.L., 1980: Platelet derived growth factor stimulates activity of low density lipo protein receptors

Tashjian A.H.Jr; Hohmann E.L.; Antoniades H.N.; Levine L., 1982: Platelet derived growth factor stimulates bone resorption via a prostaglandin mediated mechanism

Michalevicz R.; Katz F.; Stroobant P.; Janossy G.; Tindle R.W.; Hoffbrand A.V., 1986: Platelet derived growth factor stimulates growth of highly enriched multipotent hemopoietic progenitors

Witte L.D.; Cornicelli J.A., 1980: Platelet derived growth factor stimulates low density lipo protein receptor activity in cultured human fibroblasts

Williams L.T.; Antoniades H.N.; Goetzl E.J., 1983: Platelet derived growth factor stimulates mouse 3t3 cell mitogenesis and leukocyte chemo taxis through different structural determinants

Wilson E.; Laster S.M.; Gooding L.R.; Lambeth J.D., 1987: Platelet derived growth factor stimulates phagocytosis and blocks agonist induced activation of the neutrophil oxidative burst a possible cellular mechanism to protect against oxygen radical damage

Chu S H.W.; Hoban C.J.; Owen A.J.; Geyer R.P., 1985: Platelet derived growth factor stimulates rapid polyphosphoinositide breakdown in fetal human fibroblasts

Cassel D.; Rothenberg P.; Zhuang Y X.; Deuel T.F.; Glaser L., 1983: Platelet derived growth factor stimulates sodium ion hydrogen induces cytoplasmic alkalinization in nr 6 cells

Harrington M.A.; Estes J.E.; Leof E.; Pledger W.J., 1985: Platelet derived growth factor stimulates transient phosphorylation of 180000 dalton protein

Nishimura J.; Huang J.S.; Deuel T.F., 1982: Platelet derived growth factor stimulates tyrosine specific protein kinase activity in swiss mouse 3t3 cell membranes

Harrington M.A.; Wharton W.; Pledger W.J., 1987: Platelet derived growth factor stimulation of tritiated glucosamine incorporation in density arrested balb c 3t3 cells

Collins M.K.L.; Sinnett Smith J.W.; Rozengurt E., 1983: Platelet derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of swiss 3t3 cells

Levin M.; Stroobant P.; Walters M.D.S.; Cheng D.J.; Waterfield M.D.; Barratt T.M., 1986: Platelet derived growth factors as possible mediators of vascular proliferation in the sporadic hemolytic uremic syndrome

Eastment, C. T.; Sirbasku, D. A., 1978: Platelet derived growth factors for a hormone responsive rat mammary tumor cell line

Bernabei P.A.; Arcangeli A.; Casini M.; Grossi A.; Padovani R.; Ferrini P.R., 1986: Platelet derived growth factors mitogenic activity in patients with myeloproliferative disease

Jewell A.P.; Marcus R.E., 1984: Platelet derived malonyldialdehyde production in patients with thalassemia major

Carmo L.G.; Hatmi M.; Rotilio D.; Vargraftig B.B., 1985: Platelet desensitization induced by arachidonic acid is not due to cyclooxygenase inactivation and involves the endoperoxide receptor

Dumoulin M.; Tirmarche M.; Horellou M.H.; Acar J.; Samama M., 1981: Platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement

Lazarchick J.; Garddick S.L.; Hall S.A.; Genco P.W., 1987: Platelet directed antibody in the serum of patients with primary thrombotic thrombocytopenic purpura

Brodsky I.; Strayer D.R.; Gillespie D.H., 1984: Platelet dna polymerase levels in chronic myeloid leukemia implications for oncogenesis

Toghill P.J.; Green S., 1983: Platelet dynamics in chronic liver disease using the indium 111 labeled oxine label

Toghill, P. J.; Green, S.; Ferguson, R., 1977: Platelet dynamics in chronic liver disease with special reference to the role of the spleen

Setzer E.S.; Webb I.B.; Wassenaar J.W.; Reeder J.D.; Mehta P.S.; Eitzman D.V., 1982: Platelet dys function and coagulopathy in intra ventricular hemorrhage in the premature infant

Fouser L.S.; Morrow N.E.; Davis R.B., 1980: Platelet dys function associated with abdominal aortic aneurysm

Stuart M.J., 1979: Platelet dys function in homo zygous beta thalassemia

Deshmukh, S. V.; Meyer, J. S.; Mouche, R. J., 1976: Platelet dys function in migraine effect of self medication with aspirin

Phadke K.; Dean S.; Pitney W.R., 1981: Platelet dys function in myelo proliferative syndromes

Ingeberg S.; Stoffersen E., 1979: Platelet dys function in patients with vitamin b 12 deficiency

Friedman, Z.; Lamberth, E. L-Jr ; Stahlman, M. T.; Oates, J. A., 1977: Platelet dys function in the neo nate with essential fatty acid deficiency

Steinherz, P. G.; Miller, D. R.; Hilgartner, M. W.; Schmalzer, E. A., 1976: Platelet dys function in vincristine treated patients

Johnson, G. J.; Rao, G. H. R.; White, J. G., 1978: Platelet dys function induced by parenteral carbenicillin and ticarcillin studies of the dose response relationship and mechanism of action in dogs

Nishimura J.; Okamoto S.; Motomura S.; Ibayashi H., 1981: Platelet dys functions in myelo proliferative disorders the different mechanisms of abnormal responses to collagen and arachidonic acid

Bracey, A. W.; Wu, A. H. B.; Aceves, J.; Chow, T.; Carlile, S.; Hoots, W. K., 1987: Platelet dysfunction associated with wilms' tumor and hyaluronic acid

Mohri, H.; Asada, H.; Kodama, F.; Itoh, A.; Ohkubo, T., 1986: Platelet dysfunction in patients with essential thrombocythemia acquired von willebrand's disease

Cortelazzo S.; Viero P.; D'emilio A.; De Gaetano G.; Barbui T., 1986: Platelet dysfunction in splenectomized patients with hairy cell leukemia

Di-Minno, G.; Cebrone, A.; Usberti, M.; Cianciaruso, B.; Cortese, A.; Farace, M. J.; Martinez, J.; Murphy, S., 1986: Platelet dysfunction in uremia ii. correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adp or collagen

Di Minno G.; Martinez J.; Mckean M L.; De La Rosa J.; Burke J.F.; Murphy S., 1985: Platelet dysfunction in uremia multifaceted defect partially corrected by dialysis

Chignard, M.; Lefort, J.; Vargaftig, B. B., 1977: Platelet effects of arachidonic acid in dog blood part 1 lack of involvement of cyclo oxygenase in the in vivo situation

Chignard, M.; Lefort, J.; Vargaftig, B. B., 1977: Platelet effects of arachidonic acid in dog blood part 2 involvement of cyclo oxygenase in the in vitro situation

Smariga P.E.; Maynard J.R., 1982: Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cells

Jirillo, E.; Colucci, D.; De-Santis, A.; Munno, I.; Fumarola, D., 1978: Platelet electrophoretic mobility slowing factor in supernatants of human lymphocytes stimulated with phyto hem agglutinin

Passero S.; Battistini N.; Fieschi C., 1981: Platelet embolism in rabbit brain

Trusal L.R.; Guzman A.W.; Moore D.L., 1984: Platelet endothelial cell interactions in vitro following freeze thaw injury or detergent treatment

Hokama, Y., 1978: Platelet endothelial prostaglandin biochemical imbalance in sudden infant death syndrome in the new born capillary endothelial cell deficiency and or lag in maturation of prostacyclin synthetase

Takagi Y.; Dyer C.A.; Curtiss L.K., 1988: Platelet enhanced apolipoprotein e production by human macrophages a possible role in atherosclerosis

Ward P.A.; Cunningham T.W.; Mccullouch K.K.; Phan S.H.; Powell J.; Johnson K.J., 1988: Platelet enhancement of oxygen radical responses in stimulated human neutrophils identification of platelet factor as adenine nucleotide

Menter D.G.; Sloane B.F.; Steinert B.W.; Onoda J.; Craig R.; Harkins C.; Taylor J.D.; Honn K.V., 1987: Platelet enhancement of tumor cell adhesion to subendothelial matrix role of platelet cytoskeleton and platelet membrane

Farmer P.M., 1980: Platelet enzyme abnormalities in neuro psychiatric disease

Mcleish W.A.; Shaw P., 1980: Platelet estimates using a computer assisted blood smear interpretation system

Dilworth, P.; Gyde, O. H. B.; Ince, A. J., 1978: Platelet estimation in whole blood

Wu, V. Y.; Mccoy, L. E., 1977: Platelet factor 3 quantitation and characterization

Dhar J.M.; Rizvi S.N.A.; Rani S.; Goel R.G.; Gulati P.D., 1981: Platelet factor 3a time in uremia

Okuno, T.; Crockatt, D., 1977: Platelet factor 4 activity and thrombo embolic episodes

Hiti-Harper, J.; Wohl, H.; Harper, E., 1978: Platelet factor 4 an inhibitor of collagenase

Stratton J.R.; Malpass T.W.; Ritchie J.L.; Pfeifer M.A.; Harker L.A., 1982: Platelet factor 4 and beta thrombo globulin release during exercise lack of relationship to myo cardial ischemia

Cella G.; Colby S.I.; Taylor A.D.; Mccracken L.; Parisi A.F.; Sasahara A.A., 1983: Platelet factor 4 and heparin released platelet factor 4 in patients with cardio vascular disorders

Poon M C.; Hurst R.E.; Rives M.S., 1982: Platelet factor 4 and protamine sulfate neutralization of heparin fractionated according to anionic charge density

Ryo R.; Proffitt R.T.; Poger M.E.; O'bear R.; Deuel T.F., 1979: Platelet factor 4 antigen in megakaryocytes

Wu V Y.; Cohen M.P., 1984: Platelet factor 4 binding to glomerular micro vascular matrix

Kurachi, K., 1978: Platelet factor 4 crystallization and x ray diffraction studies

Levine S.P.; Moake J.L., 1984: Platelet factor 4 does not promote von willebrand factor binding to human platelets

Carr M.E.; White G.C.II.; Gabriel D.A., 1987: Platelet factor 4 enhances fibrin fiber polymerization

Burstein S.A.; Malpass T.W.; Yee E.; Kadin M.; Brigden M.; Adamson J.W.; Harker L.A., 1984: Platelet factor 4 excretion in myelo proliferative disease implications for the etiology of myelo fibrosis

Deuel T.F.; Senior R.M.; Chang D.; Griffin G.L.; Heinrikson R.L.; Kaiser E.T., 1981: Platelet factor 4 is chemo tactic for neutrophils and monocytes

White G.C.II; Marouf A.A., 1981: Platelet factor 4 levels in patients with coronary artery disease

Fuster, V.; Lewis, J. C.; Kottke, B. A.; Ruiz, C. E.; Bowie, E. J. W., 1977: Platelet factor 4 like activity in the initial stages of athero sclerosis in pigeons

Cella G.; Scattolo N.; Vio C.; Stevanato F.; Lavagnini T.; Padovan D.; Girolami A., 1986: Platelet factor 4 pf4 and heparin released platelet factor 4 hr pf4 in diabetes mellitus effect of the duration of the disease

Ek I.; Falkenberg C.; Bygdeman S.; Thunell S., 1982: Platelet factor 4 plasma levels at rest and after exercise in patients with recent myo cardial infarction

Horton J.E.; Harper J.; Harper E., 1980: Platelet factor 4 regulates osteoclastic bone resorption in vitro

Levine S.P.; Suarez A.J.; Sorenson R.R.; Raymond N.M.; Knieriem L.K., 1984: Platelet factor 4 release during exercise in patients with coronary artery disease

Shimizu T.; Ishikawa Y.; Morishima Y.; Fukuda T.; Kato K., 1985: Platelet factor 4 release from the platelets stored in platelet concentrates

Cella G.; Scottolo N.; Cappellato M.G.; Girolami A.; Strauss W.E.; Sasahara A.A., 1985: Platelet factor 4 release induced by intravenous administration of heparin

Luzzatto, G.; Fabris, F.; Mazzucato, M.; Girolami, A., 1985: Platelet factor 4 vs. beta thromboglobulin as evidence for platelet activation in myeloproliferative disorders

Fratkin J.D.; Cancilla P.A.; Debault L.E., 1980: Platelet factor and cerebral vascular endothelium platelet induced mitogenesis

Slot, J. W.; Bouma, B. N.; Montgomery, R.; Zimmerman, T. S., 1978: Platelet factor vii related antigen immuno fluorescent localization

Sultan, Y.; Jeanneau, C.; Lamaziere, J.; Malsonneuve, P.; Caen, J. P., 1978: Platelet factor viii related antigen studies in vivo after transfusion in patients with von willebrand disease

Nagano T., 1985: Platelet factor x activator activity

Ando Y.; Imamura S.; Yamagata Y.; Kitahara A.; Saji H.; Murachi T.; Kannagi R., 1987: Platelet factor xiii is activated by calpain

Saito Y.; Imada T.; Takagi J.; Kikuchi T.; Inada Y., 1986: Platelet factor xiii the collagen receptor

Thorgeirsson, G.; Robertson, A. L-Jr, 1978: Platelet factors and the human vascular wall part 2 such factors are not required for endothelial cell proliferation and migration

Thorgeirsson, G.; Robertson, A. L-Jr, 1978: Platelet factors and the human vascular wall variations in growth response between endothelial and medial smooth muscle cells

Valles J.; Aznar J.; Santos M.T., 1979: Platelet fatty acids in acute myo cardial infarction

Moore A.; Weksler B.B.; Nachman R.L., 1981: Platelet fc immuno globulin g receptor increased expression in female platelets

Moore A.; Nachman R.L., 1981: Platelet fc receptor increased expression in myelo proliferative disease

Jandrot Perrus M.; Mosesson M.W.; Denninger M H.; Menache D., 1979: Platelet fibrinogen from a subject with a congenital plasma fibrinogen abnormality fibrinogen paris i

Kozubski W.; Walkowiak B.; Cierniewski C.S.; Prusinski A., 1987: Platelet fibrinogen receptors in migraine patients

Fabris F.; Betterle C.; Casonato A.; Girolami A., 1979: Platelet fibrinogen sub cellular localization by immuno fluorescent studies in normals and in congenital afibrinogenemia

Turner W.A.; Szlag D.C.; Taylor J.D., 1985: Platelet fibronectin release induced by walker 256 rat carcinoma tumor cells

Whicher, S. J.; Brash, J. L., 1978: Platelet foreign surface interactions release of granule constituents from adherent platelets

Paulus, J. M.; Casals, F. J., 1978: Platelet formation in mediterranean macro thrombocytosis

Eynard A.R.; Tremoli E.; Caruso D.; Magni F.; Sirtori C.R.; Galli G., 1986: Platelet formation of 12 hydroxyeicosatetraenoic acid and thromboxane b 2 is increased in type iia hypercholesterolemic subjects

Kelton J.G.; Sheridan D.; Neame P.B.; Simon G.T., 1985: Platelet fragments do not contribute to elevated levels of platelet associated immunoglobulin g

Helmerhorst F.M.; Ten Berge M.T.; Van Der Plas Van Dalen C.M.; Engelfriet C.P.; Von Dem Borne A.E.G.K., 1984: Platelet freezing for serological purposes with and without a cryo preservative

Henry R.L., 1977: Platelet function

O'donnell, T. F. Jr ; Carvalho, A. C. A.; Colman, R. W.; Clowes, G. H. A. Jr, 1978: Platelet function abnormalities in a family with recurrent arterial thrombosis

Ramos O.F.; Moron E.C.; Arenas R.D., 1981: Platelet function abnormalities in acute leukemia

Mcdaniel H.G.; Maddox W.T.; Poon M C.; Rogers W.J.; Rackley C.E., 1983: Platelet function abnormalities in response to arachidonic acid in the acute phase of myo cardial infarction

Sinzinger H.; Wirthumer Hoche C., 1985: Platelet function after a single oral dose of buflomedil

Koerner K., 1983: Platelet function after shipment of room temperature platelet concentrates

Warlow, C.; Ogston, D.; Douglas, A. S., 1976: Platelet function after the administration of chlorpromazine to human subjects

Molinas F.C.; Drucker E.; Kordich L.; Reynolds M.A.; Finkielman S., 1981: Platelet function and anti thrombins in hyper lipo proteinemia type iia

Mehta J.L.; Mehta P.; Lopez L.; Ostrowski N.; Aguila E., 1984: Platelet function and biosynthesis of prostacyclin and thromboxane a 2 in whole blood after aspirin administration in human subjects

Manikeri S.R.; Kshirsagar N.A.; Karandikar S.M.; Dastur F.D.; Awatramani V.; Shah J.; Shah J.M., 1981: Platelet function and blood coagulation in tetanus

Davi' G.; Cannizzaro S.; Giubilato A.; Di Gorgi C.; Novo S.; Alaimo P.; Spatola A.; Strano A., 1986: Platelet function and calcium channel blockers effects induced by diltiazem in chd patients

Bovenzi M.; Fiorito A.; Giansante C.; Calabrese S.; Negro C., 1983: Platelet function and clotting parameters of vibration exposed foundry workers

Ziemen M., 1984: Platelet function and coagulation disorders in organophosphate intoxication

Breddin K.; Grun H., 1980: Platelet function and coagulation factors before and after the passage of micro aggregate filters

Calabrese S.; Giansante C., 1982: Platelet function and coagulation in hyper lipo proteinemia and athero sclerosis

Pekonen F.; Rasi V.; Ammala M.; Viinikka L.; Ylikorkala O., 1986: Platelet function and coagulation in normal and preeclamptic pregnancy

Triger D.R.; Malia R.G.; Preston F.E., 1988: Platelet function and coagulation in patients with hepatobiliary disorders receiving cefotetan prophylaxis

Zuppiroli A.; Cecchi F.; Ciaccheri M.; Italiani G.; Doplara A.; Longo G.; Matucci M.; Morfini M.; Rafanelli D., 1986: Platelet function and coagulation studies in patients with mitral valve prolapse

De Lorgeril M.; Reber G.; Righetti A.; Bouvier C.A., 1984: Platelet function and coronary artery disease the unstable platelet syndrome

Inoue K., 1984: Platelet function and diabetic vascular complications

Park H.S.; Kim M.W.; Kim T.J.; Hwang S.D.; Lee H.B., 1987: Platelet function and factor viii in uremia

Stenbjerg S.; Petersen J.K., 1980: Platelet function and fibrinolytic activity after a single dose of diflunisal donobid

Knudsen J.B.; Brodthagen U.; Gormsen J.; Jordal R.; Norregaard Hansen K.; Paulev P E., 1982: Platelet function and fibrinolytic activity following distance running

Staedtler R.; Von Kries R.; Goebel U., 1984: Platelet function and high dose methotrexate treatment with citrovorum factor rescue

Chediak, J. R.; Telfer, M. C.; Green, D., 1977: Platelet function and immunologic parameters in von willebrands disease following cryo precipitate and factor viii concentrate infusion

Dmoszynska Giannopoulou A.; Pluta A.; Kowalewski J., 1979: Platelet function and lipid disturbances in diabetics

Brook G.; Winterstein G.; Aviram M., 1983: Platelet function and lipo protein levels after plasma exchange in patients with familial hyper cholesterolemia

Gjesdal, K., 1976: Platelet function and plasma free fatty acids during acute myo cardial infarction and severe angina pectoris

Shastri, K. M.; Carvalho, A. C. A.; Lees, R. S., 1980: Platelet function and platelet lipid composition in the dys lipo proteinemias

Sinzinger H.; Rauscha F.; Vinazzer H., 1987: Platelet function and prostaglandins in patients with peripheral vascular disease treated with calcium dobesilate

Sato K., 1987: Platelet function and prostanoids in essential hypertension

Cortinovis A.; Crippa A.; Compagnoni G.C., 1983: Platelet function and same erythrocyte changes in patients with ischemic heart disease

Nordoy A.; Refsum N.; Thelle D.; Jaeger S., 1979: Platelet function and serum high density lipo proteins

Corash L.; Andersen J.; Poindexter B.J.; Schaefer E.J., 1981: Platelet function and survival in patients with severe hyper cholesterolemia

Vicari A.M.; Giusti M.C.; Luoni R.; Macagni A.; Medaglini S.; Seveso M.P.; Franceschi M., 1987: Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks

Seth, U.; Bhargava, M.; Vaidya, M. C.; Kumar, S., 1978: Platelet function and ultrastructure in nonthrombocytopenic bleeding of leukemia

Stathakis, N. E.; Economopoulos, T. C.; Papayannis, A. G.; Thomopoulos, D., 1977: Platelet function blood coagulation and fibrinolysis in behcets syndrome

Briel R.C.; Kunz S.; Kidess E., 1979: Platelet function coagulation and fibrinolysis during termination of missed abortion and missed labor by prostaglandin f 2 alpha and oxytocin

Pogliani E.M.; Colombi M.; Zanella A., 1986: Platelet function defect in triosephosphate isomerase deficiency

Mikhailidis D.P.; Jenkins W.J.; Barradas M.A.; Jeremy J.Y.; Dandona P., 1986: Platelet function defects in chronic alcoholism

Fuhrman B.; Brook J.G.; Aviram M., 1986: Platelet function during alimentary lipemia in type iv hyperlipidemia

Thomas R.; Hessel E.A.II.; Harker L.A.; Sands M.P.; Dillard D.H., 1981: Platelet function during and after deep surface hypo thermia

Edmunds L.H.Jr; Ellison N.; Colman R.W.; Niewiarowski S.; Rao A.K.; Addonizio V.P.Jr; Stepenson L.W.; Edie R.N., 1982: Platelet function during cardiac operation comparison of membrane and bubble oxygenators

Heim M.; Bouvenot G.; Juhan I.; Lena D.; Bartolin R.; Aillaud M F.; Simonin R., 1980: Platelet function during hyper lipo proteinemia

Dupuy, E.; Fleming, A. F.; Caen, J. P., 1978: Platelet function factor viii fibrinogen and fibrinolysis in nigerians and europeans in relation to atheroma and thrombosis

Gorski J., 1982: Platelet function in 3 cases of thrombocythemia

Aviram M.; Deckelbaum R.J.; Brook J.G., 1985: Platelet function in a case with abetalipoproteinemia

Giansante C.; Calabrese S.; Sammartini C., 1983: Platelet function in a group of lower limbs arteriopathics

Shitikova, A. S., 1978: Platelet function in acute leukemia

O'brien J.R.; Etherington M.D.; Shuttleworth R.D.; Calwell W.H., 1980: Platelet function in acute myo cardial infarction patients compared with controls

Carvalho A.C.; Quinn D.A.; Demarinis S.M.; Beitz J.G.; Zapol W.M., 1987: Platelet function in acute respiratory failure

Ohsone, T.; Yoshikawa, K.; Takahashi, Y.; Wakatsuki, Y.; Kogure, M., 1988: Platelet function in behcet's disease with special reference to the platelet specific proteins and the arachidonic acid metabolites

Haim S.; Brook J.G.; Gilhar A.; Friedman Birnbaum R.; Markel A.; Aviram M.; Marmur A.; Youdin M., 1984: Platelet function in behcets disease

Hussain M.A.M.; Hutton R.A.; Pavlidou O.; Hoffbrand A.V., 1979: Platelet function in beta thalassemia major

Ando F.; Kato M.; Goto S.; Kobayashi K.; Ichikawa H.; Kamiya T., 1983: Platelet function in bilateral acute retinal necrosis

Thaulow E., 1983: Platelet function in blood from the coronary sinus in patients with arterio sclerotic heart disease

Thaulow E., 1984: Platelet function in blood sampled through heart catheters

Rubin M.H.; Weston M.J.; Langley P.G.; White Y.; Williams R., 1979: Platelet function in chronic liver disease relationship to disease severity

Mohri H.; Maruta I.; Itoh A.; Ohkubo T., 1985: Platelet function in chronic lymphocytic leukemia

Cade J.F.; Doyle D.J.; Chesterman C.N.; Morgan F.J.; Rennie G.C., 1982: Platelet function in coronary artery disease effects of coronary surgery and sulfinpyrazone

Bygdeman, S.; Tomenius, J.; Thunell, S., 1977: Platelet function in crohns disease

Betteridge D.J.; Zahavi J.; Jones N.A.G.; Shine B.; Kakkard V.V.; Galton D.J., 1981: Platelet function in diabetes mellitus in relationship to complications glycosylated hemo globin and serum lipo proteins

Maguire L.C.; Henriksen R.A.; Strauss R.G.; Goedken M.M.; Echternacht B.; Koepke J.A.; Thompson J.S., 1980: Platelet function in donors undergoing intermittent flow centrifugation plateletpheresis or leukapheresis

Baumann B.; Hillmar I.; Hehlmann R., 1988: Platelet function in essential thrombocythemia and reactive thrombocytosis

Kaywin, P.; Mcdonough, M.; Insel, P. A.; Shattil, S. J., 1978: Platelet function in essential thrombocythemia decreased epinephrine responsiveness associated with a deficiency of platelet alpha adrenergic receptors

Garcia Escribano M.C.; Diez Marques M.L.; Lucio Cazana F.J.; Rodriguez Puyol M., 1987: Platelet function in experimental hypercholesterolemia

Bradlow B.A.; Chetty N.; Birnbaum M.; Baker S.G.; Seftel H.C., 1982: Platelet function in familial hyper cholesterolemia in south africa and the effects of probucol

Weston, M. J.; Langley, P. G.; Rubin, M. H.; Hanid, M. A.; Mellon, P.; Williams, R., 1977: Platelet function in fulminant hepatic failure and effect of charcoal hemo perfusion

Zuzel M.; Cawley J.C.; Paton R.C.; Burns G.F.; Mcnicol G.P., 1979: Platelet function in hairy cell leukemia

Zucker M.L.; Trowbridge C.; Krehbiel P.; Jackson B.; Chernoff S.B.; Dujovne C.A., 1986: Platelet function in hypercholesterolemics before and after hypolipidemic drug therapy

Parizek M.; Parizkova M.; Kubisz P., 1985: Platelet function in hyperlipoproteinemia

Baker R.I.; Manoharan A., 1988: Platelet function in myeloproliferative disorders characterization and sequential studies show multiple platelet abnormalities and change with time

Mikhailidis D.P.; Barradas M.A.; Mier A.; Boag F.; Jeremy J.Y.; Harvard C.W.H.; Dondona P., 1987: Platelet function in patients admitted with a diagnosis of myocardial infarction

Martinez Brotons F.; Portis T.; Simon R.; Perez Ayuso M.J.; Kian C.; Reynaldo C.; Gausi C., 1987: Platelet function in patients treated with verapamil comparison with dipyridamole and acetylsalicylic acid asa

Cimminiello C.; Arpaia G.; Milani M.; Uberti T.; Rocchini G.M.; Motta A.; Cristoforetti G.; Curri S.B., 1987: Platelet function in patients with acrocyanosis

Olszanska Skorek T.; Mazurowa A.; Polczynska I.; Chojnowski K.; Eichelkraut A.; Kuzmicka J., 1979: Platelet function in patients with acute myo cardial infarction after administration of acetyl salicylic acid and dipyridamole

Ding Y A.; Tung C S.; Shieh S M., 1988: Platelet function in patients with acute myocardial infarction

Ohsone, T.; Yoshikawa, K.; Kogure, M., 1988: Platelet function in patients with behcet's disease a study on platelet aggregability

Shalaev S.V.; Panchenko E.P.; Karaev A.V.; Pisareva N.A.; Ovtrakht N.V., 1987: Platelet function in physical exercise and induced myocardial ischemia in patients with ischemic heart disease

Lintula R.; Rasi V.; Ikkala E.; Borgstrom G.H.; Vuopio P., 1981: Platelet function in pre leukemia

Colli S.; Maderna P.; Tremoli E.; Colombo F.; Canesi B., 1982: Platelet function in rheumatoid arthritis

Johnson G.J.; Holloway D.E.; Hutton S.W.; Duane W.C., 1981: Platelet function in scurvy and experimental human vitamin c deficiency

Almagro D.; Gonzalez A.; Svarch E.; Corral J.F., 1979: Platelet function in sickle cell anemia

Gruppo, R. A.; Glueck, H. I.; Granger, S. M.; Miller, M. A., 1977: Platelet function in sickle cell anemia

Naesh O.; Friis J.T.; Hindberg I.; Winther K., 1985: Platelet function in surgical stress

Retief, F. P.; Vandenplas, L., 1970: Platelet function in the bantu

Buchanan G.R.; Handin R.I., 1976: Platelet function in the chediak higashi syndrome

Giansante C.; Calabrese S.; Sammartini C.; Feruglio F.S., 1982: Platelet function in transitory cerebral ischemia

Colette C.; Pares Herbute N.; Monnier L.H.; Cartry E., 1988: Platelet function in type i diabetes effects of supplementation with large doses of vitamin e

Koerner K., 1984: Platelet function of room temperature platelet concentrates stored in a new plastic material with high gas permeability

Nishimura J.; Okamoto S.; Matsumoto M.; Ibayashi H., 1980: Platelet function of vitamin e deficient rats

Thaulow E.; Erikssen J.; Myhre E.; Stormorken H.; Hellem A., 1982: Platelet function related to the development and presenting symptoms in coronary artery disease an epidemiological study in apparently healthy men

Clemmons R.M.; Bliss E.L.; Dorsey Lee M.R.; Seachord C.L.; Meyers K.M., 1983: Platelet function size and yield in whole blood and in platelet rich plasma prepared using differing centrifugation force and time in domestic and food producing animals

Yardumian D.A.; Mackie I.J.; Brennan E.C.; Bull H.; Machin S.J., 1986: Platelet function studies during and after infusions of zk 36374 a stable prostacyclin analog to healthy volunteers

Mehta, J.; Mehta, P., 1979: Platelet function studies in heart disease 6. enhanced platelet aggregate formation activity in congestive heart failure inhibition by sodium nitroprusside

Pfliegler G.; Boda Z.; Udvardy M.; Kiss A.; Telek B.; Pecze K.; Nagy P.; Rak K., 1986: Platelet function studies in myeloproliferative disorders

Miller J.L., 1984: Platelet function testing an improved approach utilizing lumi aggregation and an interactive computer system

Weiss, H. J., 1976: Platelet function tests and their interpretation

Uchiyama S.; Takeuchi M.; Osawa M.; Kobayashi I.; Maruyama S.; Aosaki M.; Hirosawa K., 1983: Platelet function tests in thrombotic cerebro vascular disorders

Hamilton R.W.; Shaikh B.S.; Ottie J.N.; Storch A.E.; Saleem A.; White J.G., 1980: Platelet function ultrastructure and survival in the may hegglin anomaly

Burykina I.A.; Kovaleva T.N.; Ignatenko S.I.; Mertsalova N.N.; Chepurov A.K., 1981: Platelet functional activity in the early period of artificial heart implantation

Lanza F.; Cazenave J P.; Hemmendinger S.; Stierle A.; Tranchant C.; Warter J M., 1987: Platelet functions alpha 2 adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of steinert

Cutcudache C.; Mateescu O.; Boldescu G.; Antal C.; Nestor G., 1986: Platelet functions and blood coagulation in chronic renal insufficiency

Akkerman, J. W. N.; Rijksen, G.; Gorter, G.; Staal, G. E. J., 1984: Platelet functions and energy metabolism in a patient with hexo kinase ec 2.7.1.1 deficiency

Mcgregor L.; Morazain R.; Renaud S., 1981: Platelet functions and fatty acid composition of platelet phospho lipids in spontaneously hypertensive rats fed saturated or poly unsaturated fats

Sagi A.; Creter D.; Goldman J.; Djaldetti M., 1981: Platelet functions before during and after labor

Bern, M. M., 1978: Platelet functions in diabetes mellitus

Kasturi, J.; Saraya, A. K., 1978: Platelet functions in dys proteinemia

Dale, J.; Myhre, E., 1977: Platelet functions in patients with aortic ball valves

Renaud S.; Dumont E.; Godsey F.; Suplisson A.; Thevenon C., 1979: Platelet functions in relation to dietary fats in farmers from 2 regions of france

Berrettini, W. H.; Umberkoman-Wiita, B.; Nurnberger, J. I. Jr ; Vogel, W. H.; Gershon, E. S.; Post, R. M., 1982: Platelet gamma amino butyric acid trans aminase ec 2.6.1.19 in affective illness

Leoncini G.; Maresca M.; Balestrero F.; Polvani C.; Armani U.; Piana A., 1987: Platelet glucose metabolism in type i diabetic subjects

Mangano R.M.; Schwarcz R., 1981: Platelet glutamate and aspartate uptake in huntingtons disease

Guidi G.; Schiavon R.; Sheiban I.; Perona G., 1986: Platelet glutathione peroxidase activity is impaired in patients with coronary heart disease

Nibu K.; Ideguchi H.; Hamasaki N., 1982: Platelet glyco proteins of bernard soulier syndrome analysis by iso electric focusing and sodium dodecyl sulfate poly acrylamide gel electrophoresis in a 2 dimensional technique

Okumura, T.; Jamieson, G. A., 1976: Platelet glycocalicin a single receptor for platelet aggregation induced by thrombin or ristocetin

Okumura, T.; Hasitz, M.; Jamieson, G. A., 1978: Platelet glycocalicin interaction with thrombin and role as thrombin receptor of the platelet surface

Solum N.O.; Hagen I.; Filion Myklebust C.; Stabaek T., 1980: Platelet glycocalicin its membrane association and solubilization in aqueous media

Okumura, T.; Jamieson, G. A., 1976: Platelet glycocalicin part 1 orientation of glyco proteins of the human platelet surface

Okumura, T.; Lombart, C.; Jamieson, G. A., 1976: Platelet glycocalicin part 2 purification and characterization

Tegos, C.; Beutler, E., 1979: Platelet glycolysis in platelet storage 3. the inability of platelets to utilize exogenous citrate

Beutler, E.; Kuhl, W., 1980: Platelet glycolysis in platelet storage 4. the effect of supplemental glucose and adenine

Tegos C.; Beutler E., 1979: Platelet glycolysis in platelet storage part 1 the glycolytic enzymes

Pidard D., 1987: Platelet glycoprotein complex iib iiia a polyvalent membrane receptor?

Komarnicki M.; Twardowski T., 1987: Platelet glycoprotein concentrations in patients with chronic uremia

Tomiyama Y.; Kurata Y.; Mizutani H.; Kanakura Y.; Tsubakio T.; Yonezawa T.; Tarui S., 1987: Platelet glycoprotein iib as a target antigen in two patients with chronic idiopathic thrombocytopenic purpura

Bray P.F.; Rosa J P.; Johnson G.I.; Shiu D.T.; Cook R.G.; Lau C.; Kan Y.W.; Mcever R.P.; Shuman M.A., 1987: Platelet glycoprotein iib chromosomal localization and tissue expression

Charo I.F.; Bekeart L.S.; Phillips D.R., 1987: Platelet glycoprotein iib iiia like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix

Pischel K.D.; Bluestein H.G.; Woods V.L.Jr, 1988: Platelet glycoproteins ia ic and iia are physicochemically indistinguishable from the very late activation antigens adhesion related proteins of lymphocytes and other cell types

Rybak M.E.; Renzulli L.A.; Bruns M.J.; Cahaly D.P., 1988: Platelet glycoproteins iib and iiia as a calcium channel in liposomes

Levene R.B.; Rabellino E.M., 1986: Platelet glycoproteins iib and iiia associated with blood monocytes are derived from platelets

Charo I.F.; Fitzgerald L.A.; Steiner B.; Rall S.C.Jr; Bekeart L.S.; Phillips D.R., 1986: Platelet glycoproteins iib and iiia evidence for a family of immunologically and structurally related glycoproteins in mammalian cells

Leoncini G.; Maresca M.; Balestrero F.; Armani U.; Piana A., 1984: Platelet glyoxalases in thrombocytosis

Strobl Jaeger E.; Fitscha P.; Kaliman J.; Widhalm K.; Sinzinger H., 1986: Platelet half life in comparison to other in vivo platelet function parameters such as thromboxane b 2 beta thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia

Sinzinger H.; Fitscha P.; Peskar B.A., 1986: Platelet half life plasma thromboxane b 2 and circulating endothelial cells in peripheral vascular disease

Yarom R.; Lijovetzky G.; Havivi Y., 1981: Platelet heterogeneity and dense tubular system changes on activation

Leone G.; Agostini A.; Decrescenzo A.; Bizzi B., 1979: Platelet heterogeneity relationship between buoyant density size lipid per oxidation and platelet age

Theodorou A.E.; Hale A.S.; Davies S.L.; Katona C.L.E.; Yamaguchi Y.; Horton R.W.; Kelly J.S.; Paykel E.S., 1986: Platelet high affinity adrenoceptor binding sites labeled with the agonist tritiated uk 14304 in depressed patients and matched controls

Stux S.; Pitman T.; Dubey D.; Gazit E.; Ervin T.; Yunis E.J., 1980: Platelet hla typing and cross matching by a direct micro cyto toxic assay a new method employing carboxy fluorescein di acetate stained platelets

Luck P.; Mikhailidis D.P.; Dashwood M.R.; Barradas M.A.; Sever P.S.; Dandona P.; Wakeling A., 1983: Platelet hyper aggregability and increased alpha adrenoceptor density in anorexia nervosa

Remuzzi G.; Mecca G.; Marchesi D.; Livio M.; De Gaetano G.; Donati M.B.; Silver M.J., 1979: Platelet hyper aggregability and the nephrotic syndrome

Kun-Yu, K., 1978: Platelet hyper aggregability and thrombosis in patients with thrombocythemia

Walter E.; Deppermann D.; Andrassy K.; Koderisch J., 1981: Platelet hyper aggregability as a consequence of the nephrotic syndrome

Wu, K. K.; Barnes, R. W.; Hoak, J. C., 1976: Platelet hyper aggregability in idiopathic recurrent deep vein thrombosis

Kusunoki M.; Kimura K.; Nagatsuka K.; Isaka Y.; Uyama O.; Yoneda S.; Abe H., 1982: Platelet hyper aggregability in ischemic cerebro vascular disease and effects of aspirin

Lou, H. C.; Nielsen, J. D.; Bomholt, A.; Gormsen, J., 1977: Platelet hyper aggregability in young patients with completed stroke

Bensoussan, D.; Levy-Toledano, S.; Caen, P.; Canivet, J.; Passa, P., 1975: Platelet hyper aggregation and increased plasma level of von willebrand factor in diabetics with retinopathy

Shattil, S. J.; Anaya-Galindo, R.; Bennett, J.; Colman, R. W.; Cooper, R. A., 1975: Platelet hyper sensitivity induced by cholesterol incorporation

Fitscha P.; Sinzinger H., 1984: Platelet hyperactivity during acute migraine attack

Mueller H.S.; Rao P.S.; Greenberg M.A.; Buttrick P.M.; Sussman I.I.; Levite H.A.; Grose R.M.; Perez Davila V.; Strain J.E.; Spaet T.H., 1986: Platelet hyperactivity in acute myocardial infarction in man effects of prostacyclin

Kenny M.W.; George A.J.; Stuart J., 1980: Platelet hyperactivity in sickle cell disease a consequence of hypo splenism

Szenasi P.; Toth L.; Romics L.; Kammerer L., 1988: Platelet hyperaggregability and hypoaggregability in different microangiopathic complications of diabetes mellitus

Solvay H.; Kahn M.; Cloarec M.; Van De Merckt J.; Sneppe R.; Schram E.; Fenollar J.V., 1986: Platelet hyperaggregability blood prostacyclin and dipyridamole

Norris, P. G.; Rivers, J. K.; Machin, S.; Dowd, P. M.; Griffiths, W. A. D., 1987: Platelet hyperaggregability in a patient with klinefelter's syndrome and leg ulcers

Stead R.J.; Barradas M.A.; Mikhailidis D.P.; Jeremy J.Y.; Hodson M.E.; Batten J.C.; Dandona P., 1987: Platelet hyperaggregability in cystic fibrosis

Rubenfire M.; Blevins R.D.; Barnhart M.; Housholder S.; Selik N.; Mammen E.F., 1986: Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries

Bennett A.; Cameron J.S., 1987: Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration

Yardumian D.A.; Mackie I.J.; Bull H.; Goldstone A.H.; Machin S.J., 1985: Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analog zk 36374

Cordova C.; Musca A.; Violi F.; Alessandri C.; Perrone A.; Balsano F., 1985: Platelet hyperfunction in patients with chronic airways obstruction

O'regan, S.; Fong, J. S. C., 1978: Platelet hypo aggregability in hypo thyroid rats

Kelton J.G.; Smith J.W.; Santos A.V.; Murphy W.G.; Horsewood P., 1987: Platelet igg fc receptor

George J.N.; Saucerman S., 1988: Platelet igg iga igm and albumin correlation of platelet and plasma concentrations in normal subjects and in patients with itp or dysproteinemia

Anderson G.M.; Minderaa R.B.; Van Benthem P P.G.; Volkmar F.R.; Cohen D.J., 1984: Platelet imipramine binding in autistic subjects

Pecknold J.C.; Chang H.; Fleury D.; Koszychi D.; Quirion R.; Nair N.P.V.; Suranyi Cadotte B.E., 1987: Platelet imipramine binding in patients with panic disorder and major familial depression

Levin M.; Holland P.C.; Nokes T.J.C.; Novelli V.; Mola M.; Levinsky R.J.; Dillon M.J.; Barratt T.M.; Marshall W.C., 1985: Platelet immune complex interaction in pathogenesis of kawasaki disease and childhood polyarteritis

Schultz, J.; Disciullo, S. O.; Abuelo, J. G., 1977: Platelet immunoassay as a simple and sensitive technique for the detection of antigens

Mackie I.J.; Jones R.; Machin S.J., 1984: Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs

De Castro M.F.; Viloria A.; Larrocha C.; Latorre P.; Tafalla C.; Jimenez M.C., 1987: Platelet indices evaluation and clinical significance

Rosen R.; Dausch W.; Beck E.; Klaus W., 1987: Platelet induced aggravation of acute ischemia in an isolated rabbit heart model

Cohen R.A., 1985: Platelet induced neurogenic coronary contractions due to accumulation of the false neurotransmitter 5 hydroxytryptamine

Leveille A.S.; Morse P.H., 1981: Platelet induced retinal neo vascularization in leukemia

Baker, M. A.; Taub, R. N., 1976: Platelet induced tolerance in the production of hetero anti sera to human leukemia associated antigens

Genton, E.; Gent, M.; Hirsh, J.; Harker, L. A., 1975: Platelet inhibiting drugs in the prevention of clinical thrombotic disease part 2

Eckel, R. H.; Crowell, E. B. Jr ; Waterhouse, B. E.; Bozdech, M. J., 1977: Platelet inhibiting drugs in thrombotic thrombocytopenic purpura

Saxon, A.; Kattlove, H. E., 1976: Platelet inhibition by sodium nitroprusside a smooth muscle inhibitor

Cress, D. C.; Metcalf, W. K., 1975: Platelet inhibition of human lymphocyte phyto hem agglutinin induced blastoid transformation

Bergstein, J. M., 1976: Platelet inhibition of renal cortical fibrinolytic activity in the rabbit

Aukland A.; Hurlow R.A.; George A.J.; Stuart J., 1982: Platelet inhibition with ticlopidine in athero sclerotic intermittent claudication

Cheseboro J.H.; Fuster V., 1986: Platelet inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty the basis of their use data from animal studies clinical trial data and current recommendations

Donadio J.V.Jr; Ilstrup D.M.; Holley K.E.; Romero J.C., 1988: Platelet inhibitor treatment of diabetic nephropathy a 10 year prospective study

Hicks G.L.Jr; Jensen L.A.; Norsen L.H.; Quinn J.R.; Stewart S.S.; Deweese J.A., 1985: Platelet inhibitors and hydroxyethyl starch safe and cost effective interventions in coronary artery surgery

Rothlin, M. E.; Pfluger, N.; Speiser, K.; Goebel, N.; Krayenbuhl, H. P.; Steinbrunn, W.; Turina, M.; Senning, A., 1985: Platelet inhibitors vs. anticoagulants for prevention of aorto coronary bypass graft occlusion

O'brien W.F.; Knuppel R.A.; Saba H.I.; Angel J.L.; Benoit R.; Bruce A., 1987: Platelet inhibitory activity in placentas from normal and abnormal pregnancies

Norcott H.C.; Goldman M.; Hawker R.J.; Rafiqi E.I.; Drolc Z.; Mccollum C.N., 1982: Platelet inhibitory drugs an in vivo method of evaluation in patients

Fiedel B.A.; Potempa L.A.; Frenzke M.E.; Simpson R.M.; Gewurz H., 1982: Platelet inhibitory effects of c reactive protein preparations are due to a co isolating low molecular weight factor

Miragliotta G.; Colucci M.; Semeraro N.; Fumarola D., 1981: Platelet injury and stimulation of leukocyte pro coagulant activity in vitro by a lipo poly saccharide from haemophilus influenzae type b

Maurer, H. M.; Haggins, J. C.; Still, W. J. S., 1976: Platelet injury during photo therapy

Hamilton J.; Subbarao V.; Granack K.; Ts'ao C., 1986: Platelet interaction with a pancreatic ascites tumor

Larsen N.E.; Horne W.C.; Simons E.R., 1979: Platelet interaction with active and tosyllysylchloromethyl ketone inactivated alpha thrombin

Clawson, C. C.; White, J. G., 1980: Platelet interaction with bacteria 5. ultrastructure of congenital afibrinogenemic platelets

Clawson, C. C.; White, J. G.; Herzberg, M. C., 1980: Platelet interaction with bacteria 6. contrasting the role of fibrinogen and fibronectin

Baumgartner, H. R., 1977: Platelet interaction with collagen fibrils in flowing blood part 1 reaction of human platelets with a chymotrypsin digested subendothelium

Baumgartner, H. R.; Tschopp, T. B.; Weiss, H. J., 1977: Platelet interaction with collagen fibrils in following blood part 2 impaired adhesion aggregation in bleeding disorders a comparison with subendothelium

Wechezak, A. R.; Mansfield, P. B.; Way, S. A., 1975: Platelet interaction with cultured endothelial cells following in vitro injury

Groves H.M.; Kinlough Rathbone R.L.; Richardson M.; Moore S.; Mustard J.F., 1979: Platelet interaction with damaged rabbit aorta

Aviram M.; Brook J.G., 1983: Platelet interaction with high and low density lipo proteins

Gloster, E. S.; Stemerman, M. B.; Spaet, T. H., 1976: Platelet interaction with human umbilical cord vascular basement membrane

Zucker-Franklin, D.; Rosenberg, L., 1977: Platelet interaction with modified articular cartilage its possible relevance to joint repair

Niewiarowski, S.; Regoeczi, E.; Stewart, G. J.; Senyi, A. F.; Mustard, J. F., 1972: Platelet interaction with polymerizing fibrin

Turitto V.T.; Weiss H.J.; Baumgartner H.R., 1984: Platelet interaction with rabbit subendothelium in von willebrands disease altered thrombus formation distinct from defective platelet adhesion

Eldor A.; Vlodavsky I.; Martinowicz U.; Fuks Z.; Coller B.S., 1985: Platelet interaction with subendothelial extracellular matrix platelet fibrinogen interactions are essential for platelet aggregation but not for the matrix induced release reaction

Turitto V.T.; Baumgartner H.R., 1979: Platelet interaction with subendothelium in flowing rabbit blood effect of blood shear rate

Solomon D.D.; Cowan D.H.; Anderson J.M.; Walton A.G., 1979: Platelet interaction with synthetic co poly peptide films

Vlodavsky I.; Eldor A.; Hyam E.; Atzmon R.; Fuks Z., 1982: Platelet interaction with the extracellular matrix produced by cultured endothelial cells a model to study the thrombogenicity of isolated subendothelial basal lamina

Sutherland G.R.; King M.E.; Peerless S.J.; Vezina W.C.; Brown G.W.; Chamberlain M.J., 1982: Platelet interaction within giant intra cranial aneurysms

Skerl K.G.; Calderone R.A.; Sreevalsan T., 1981: Platelet interactions with candida albicans

Hanson S.R.; Kotze H.F.; Savage B.; Harker L.A., 1985: Platelet interactions with dacron vascular grafts a model of acute thrombosis in baboons

Walz D.A.; Penner J.; Barnhart M.I., 1984: Platelet interactions with poly lysine coated beads a microscopic and chemical analysis

Tablin F.; Taube D., 1987: Platelet intermediate filaments detection of a vimentin like protein in human and bovine platelets

Haller H.; Lenz T.; Thiede M.; Luedersdorf M.; Kribben A.; Distler A.; Philipp T., 1987: Platelet intracellular free calcium and hypertension

Silva P.M.R.; Cordeiro R.S.B.; Martins M.A.; Henriques M.G.M.O.; Vargaftig B.B., 1986: Platelet involvement in rat paw edema induced by 2 methoxy platelet activating factor

Oxholm, P.; Winther, K., 1987: Platelet involvement in salivary gland inflammation in patients with primary sjogren's syndrome

Koyama A.; Inage H.; Sano M.; Narita M.; Tojo S.; Neild G.H.; Cameron J.S., 1985: Platelet involvement in the nephritis of acute serum sickness in rabbits protection by dipyridamole and fut 175

Harker L.A.; Hazzard W., 1979: Platelet kinetic studies in patients with hyper lipo proteinemia effects of clofibrate therapy

Hessel E.A.II; Schmer G.; Dillard D.H., 1980: Platelet kinetics during deep hypo thermia

Peters A.M.; Rozkovec A.; Bell R.N.; Hallidie Smith K.A.; Goodwin J.F.; Lavender J.P., 1982: Platelet kinetics in congenital heart disease

Bel Ali Z.; Dufour V.; Najean Y., 1987: Platelet kinetics in human immunodeficiency virus induced thrombocytopenia

Torubarova N.A.; Akopyan L.E., 1979: Platelet kinetics in idiopathic thrombocytopenic purpura following splenectomy in children

Hanson S.R.; Slichter S.J., 1985: Platelet kinetics in patients with bone marrow hypoplasia evidence for a fixed platelet requirement

Ricevuti G.; Mazzone A.; Rizzo S.C., 1985: Platelet kinetics in patients with idiopathic thrombocytopenic purpura

Stoll D.; Cines D.B.; Aster R.H.; Murphy S., 1985: Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia

Taytard, A.; Guenard, H.; Villemin, L.; Bouvot, J. L.; Vergeret, J.; Ducassou, D.; Piquet, Y.; Freour, P., 1986: Platelet kinetics in stable atopic asthmatic patients

Kutti J.; Bergstrom A L., 1981: Platelet kinetics in systemic lupus erythematosus with special reference to cortico steroid and azathioprine therapy

Tsymbal I.N.; Plakhuta T.G., 1986: Platelet lactate dehydrogenase activity thrombocytokinetics and some aspects of thrombocytopathy treatment in children

Mccue J.P.; Stevens D.J.; Kermon V.L.; Ashe M.C.S.; Heim L.R., 1980: Platelet lesion of collection

Coeffier E.; Joseph D.; Prevost M C.; Vargaftig B.B., 1987: Platelet leukocyte interaction activation of rabbit platelets by fmlp stimulated neutrophils

Jungi T.W.; Spycher M.O.; Nydegger U.E.; Barandun S., 1986: Platelet leukocyte interaction selective binding of thrombin stimulated platelets to human monocytes polymorphonuclear leukocytes and related cell lines

Ratiff N.B.; Gerrard J.M.; White J.G., 1979: Platelet leukocyte interactions following arterial endothelial injury

Tindall H.; Paton R.C.; Zuzel M.; Mcnicol G.P., 1981: Platelet life span in diabetics with and without retinopathy

Wallenburg H.C.S.; Van Kessel P.H., 1979: Platelet life span in pregnancies resulting in small for gestational age infants

Kono, N.; Mizokami, T.; Ten, C. P.; Wakasugi, A., 1980: Platelet like bodies in the urine of a patient with acute glomerulo nephritis

Kono, N.; Arai, Y.; Okazaki, T.; Yanagisawa, M.; Machida, T., 1978: Platelet like bodies in urine of idiopathic renal bleeding

Kono, N.; Mizokami, T.; Wakasugi, A.; Hashimoto, T., 1978: Platelet like bodies in urine their relationship to renal functions and platelets in blood

Schafer A.I.; Turner N.A.; Handin R.I., 1982: Platelet lip oxygenase dependent oxygen burst evidence for differential activation of lip oxygenase in intact and disrupted human platelets

Owen J.S.; Hutton R.A.; Day R.C.; Bruckdorfer K.R.; Mcintyre N., 1981: Platelet lipid composition and platelet aggregation in human liver disease

Kasimova G.M.; Mirtalipov D.T.; Abidov A.A.; Akbarov V.Z., 1987: Platelet lipid composition in diabetes mellitus as a function of the level of microangiopathy

Bottomley J.M.; Hanington E.; Jones R.J.; Chapman D., 1982: Platelet lipid composition in human migraine

Vlachakis N.D.; Aledort L., 1979: Platelet lipid per oxides as determinant of platelet survival and sympathetic stimulation in patients with hypertension

Okamoto F., 1984: Platelet lipid peroxides in acute cerebral vascular disease

Lopes-Virella, M. F.; Sarji, K.; Virella, G.; Colwell, J. A., 1976: Platelet lipo proteins a comparative study with serum lipo proteins

Plachetka J.R.; Salomon N.W.; Larson D.F.; Copeland J.G., 1980: Platelet loss during experimental cardio pulmonary bypass and its prevention with prostacyclin

Aydar S.; Yesilcimen K.; Numanoglu S.; Sonmezdag A., 1987: Platelet lymphocyte adherence in children after surgery

Leoncini G.; Balestrero F.; Maresca M.; Armani U.; Piana A., 1984: Platelet lysosomal enzymes are normal in myeloproliferative disorders

Bodzenta A.; Bielawiec M.; Krupinski K.; Wojtukiewicz M., 1982: Platelet malondialdehyde and plasma thromboxane b 2 formation in patients with obliterative arterio sclerosis of the lower limbs

Sullivan J.M.; Taylor J.C.; Samaha J.K., 1980: Platelet malondialdehyde in cardio vascular disease effect of prosthetic heart valves and cardioactive drugs on production

Weiss H.J.; Lages B., 1981: Platelet malondialdehyde production and aggregation responses induced by arachidonate prostaglandin g 2 collagen and epinephrine in 12 patients with storage pool deficiency

Nenci G.G.; Parise P.; Capodicasa E.; Berrettini M., 1983: Platelet malondialdehyde production kinetics after cyclo oxygenase block a study performed with a modified high sensitivity assay

Stuart M.J., 1979: Platelet malonyldialdehyde formation an indicator of platelet hyper function

Yehuda R.; Edell W.S.; Meyer J.S., 1987: Platelet mao activity and psychosis proneness in college students

Meltzer H.Y.; Lowy M.T.; Locascio J.J., 1988: Platelet mao activity and the cortisol response to dexamethasone in major depression

Schalling D.; Edman G.; Asberg M.; Oreland L., 1988: Platelet mao activity associated with impulsivity and aggressivity

Poirier M.F.; Loo H.; Mitrani N.; Benkelfat C.; Askienazy S.; Le Fur G., 1987: Platelet mao activity in clinical subtypes of depression and dst suppression

Alexopoulos G.S.; Young R.C.; Lieberman K.W.; Shamoian C.A., 1987: Platelet mao activity in geriatric patients with depression and dementia

Quintana J., 1988: Platelet mao deamination of serotonin in depressed patients changes after imipramine treatment and clinical correlations

Almay B.G.L.; Von Knorring L.; Oreland L., 1987: Platelet mao in patients with idiopathic pain disorders

Evans G.O.; Smith D.E.C., 1986: Platelet measurements in the common marmoset callithrix jacchus

Fass R.J.; Copelan E.A.; Brandt J.T.; Moeschberger M.L.; Ashton J.J., 1987: Platelet mediated bleeding caused by broad spectrum penicillins

Addonizio V.P.; Wetstein L.; Fisher C.A.; Feldman P.; Strauss J.F.; Harken A.H., 1982: Platelet mediated cardiac ischemia

Kruth H.S., 1985: Platelet mediated cholesterol accumulation in cultured aortic smooth muscle cells

Jelenska M.M.; Kopec M., 1983: Platelet mediated collagen and fibrin retraction effect of prostaglandins cyclic amp calcium antagonists and n ethyl maleimide

Slezak S.; Symer D.E.; Shin H.S., 1987: Platelet mediated cytotoxicity role of antibody and c3 and localization of the cytotoxic system in membranes

Haque A.; Cuna W.; Bonnel B.; Capron A.; Joseph M., 1985: Platelet mediated killing of larvae from different filarial species in the presence of dipetalonema viteae stimulated immunoglobulin e antibodies

Mlczoch, J.; Tucker, A.; Weir, E. K.; Reeves, J. T.; Grover, R. F., 1978: Platelet mediated pulmonary hypertension and hypoxia during pulmonary micro embolism reduction by platelet inhibition

Bolli R.; Ware J.A.; Brandon T.A.; Weilbaecher D.G.; Mace M.L.Jr, 1984: Platelet mediated thrombosis in stenosed canine coronary arteries inhibition by nicergoline a platelet active alpha adrenergic antagonist

De Clerck F.; Van Nueten J.M., 1983: Platelet mediated vascular contractions inhibition by flunarizine a calcium entry blocker

De Clerck F.; Van Nueten J.M., 1982: Platelet mediated vascular contractions inhibition of the serotonergic component by ketanserin

De Clerck F.; Van Gorp L.; Beetens J.; Reneman R.S., 1985: Platelet mediated vascular permeability in the rat a predominant role for 5 hydroxytryptamine

Zubenko, G. S.; Cohen, B. M.; Boller, F.; Malinakova, I.; Keefe, N.; Chojnacki, B., 1987: Platelet membrane abnormality in alzheimer's disease

Peerschke E.I.B., 1986: Platelet membrane alterations induced by the local anesthetic dibucaine

Takahashi Y.; Miyataka K.; Yamamoto H.; Masuyama H.; Mikami S., 1981: Platelet membrane bound factor viii related antigen immuno cytochemical evidence of its release by adp and collagen

Resink T.J.; Tkachuk V.A.; Erne P.; Buhler F.R., 1986: Platelet membrane calmodulin stimulated calcium atpase altered activity in essential hypertension

Niewiarowski S., 1987: Platelet membrane components and receptors

Phillips, D. R.; Agin, P. P., 1977: Platelet membrane defects in glanzmanns thrombasthenia evidence for decreased amounts of 2 major glyco proteins

Siess W.; Roth P.; Scherer B.; Kurzmann I.; Boehlig B.; Weber P.C., 1980: Platelet membrane fatty acids platelet aggregation and thromboxane formation during a mackerel diet

Berlin E.; Shapiro S.G.; Friedland M., 1984: Platelet membrane fluidity and aggregation of rabbit platelets

Zubenko G.S.; Reynolds C.F.IIi; Perel J.M.; Decker C.; Malinakova I., 1988: Platelet membrane fluidity and treatment response in cognitively impaired depressed elderly initial results

Zubenko, G. S.; Cohen, B. M.; Reynolds, C. F-Iii ; Boller, F.; Teply, I.; Chojnacki, B., 1987: Platelet membrane fluidity identifies a clinical subtype of alzheimer's disease

Zubenko, G. S.; Cohen, B. M.; Reynolds, C. F-Iii ; Boller, F.; Malinakova, I.; Keefe, N., 1987: Platelet membrane fluidity in alzheimer's disease and major depression

Jenkins, C. S. P.; Ten-Cate, J. W.; Clemetson, K. J., 1976: Platelet membrane glyco proteins a role in the hemostatic process

George, J. N., 1976: Platelet membrane glyco proteins alteration during storage of human platelet concentrates

Raymond S.L.; Dodds W.J., 1979: Platelet membrane glyco proteins in normal dogs and dogs with hemostatic defects

Jamieson G.A.; Okumura T.; Fishback B.; Johnson M.M.; Egan J.J.; Weiss H.J., 1979: Platelet membrane glyco proteins in thrombasthenia bernard soulier syndrome and storage pool disease

Clezardin P.; Mcgregor J.L.; Dechavanne M.; Clemetson K.J., 1985: Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis

George J.N.; Pickett E.B.; Heinz R., 1988: Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates

Parise L.V.; Phillips D.R., 1985: Platelet membrane glycoprotein iib iiia complex incorporated into phospholipid vesicles preparation and morphology

Pytela R.; Pierschbacher M.D.; Ginsberg M.H.; Plow E.F.; Ruoslahti E., 1986: Platelet membrane glycoprotein iib iiia member of a family of arginine glycine aspartic acid specific adhesion receptors

Beardsley D.S.; Spiegel J.E.; Jacobs M.M.; Handin R.I.; Lux S.E.Iv, 1984: Platelet membrane glycoprotein iiia contains target antigens that bind anti platelet antibodies in immune thrombocytopenias

Roche Asensio M.J.; Faure Nogueras E.; Cuesta Munoz J.; Blasco Comenge M.C.; Gutierrez Martin M., 1986: Platelet membrane glycoproteins their correlation with the degree of metabolic compensation in diabetic patients

Oxman T.E.; Hitzemann R.J.; Smith R., 1982: Platelet membrane lipid composition and the frequency of migraine

George J.N.; Pickett E.B.; Heinz R., 1986: Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate

Rendu F.; Viret J.; Daveloose D.; Levy Toledano S.; Leterrier F., 1985: Platelet membrane molecular organization relationship with membrane bound calcium

Pipili, E., 1985: Platelet membrane potential simultaneous measurement of 3' 3' dipropylthiadicarbocyanine iodide fluorescence and optical density

Coller B.S.; Zarrabi M.H., 1981: Platelet membrane studies in the may hegglin anomaly

Asch A.S.; Leung L.L.K.; Polley M.J.; Nachman R.L., 1985: Platelet membrane topography colocalization of thrombospondin and fibrinogen with the glycoprotein iib iiia complex

Mcgill M.; Fugman D.A.; Vittorio N.; Darrow C., 1987: Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits

Rozenberg A.E.; Markov Kh M., 1983: Platelet membranes and aggregation in spontaneously hypertensive rats

Kilkson H.; Holme S.; Murphy S., 1984: Platelet metabolism during storage of platelet concentrates at 22 celsius

Jen C.J.; Mcintire L.V., 1986: Platelet microtubules in clot structure formation and contractile force generation investigation of a controversy

Duquesnoy, R. J.; Lorentzen, D. F.; Aster, R. H., 1975: Platelet migration inhibition a new method for detection of platelet antibodies

Kakoma, I.; Carson, C. A.; Ristic, M.; Stephenson, E. M.; Hildebrandt, P. K.; Huxsoll, D. L., 1978: Platelet migration inhibition as an indicator of immunologically mediated target cell injury in canine ehrlichiosis

Maples, J. A.; Yokoyama, M. M.; Inboriboon, P.; Inboriboon, A.; Chao, W., 1977: Platelet migration inhibition test for platelet antibodies parameters and simplified methodology

Aviram M.; Maor I.; Rosenblat M.; Dankner G.; Brook J.G., 1988: Platelet modified lipoprotein induced by thrombin effect of whole blood and plasma

Rhee B G.; Hall E.R.; Mcintire L.V., 1986: Platelet modulation of polymorphonuclear leukocyte shear induced aggregation

Sahai, S.; Arora, R. C.; Meltzer, H. Y., 1981: Platelet mono amine oxidase 1. effect of temperature anti coagulant and centrifugation technique

Rosen A.J.; Wirtschafter D.; Pandey G.N.; Davis J.M., 1982: Platelet mono amine oxidase activity and behavioral response to pharmaco therapy in psychiatric patients

Van Kammen D.P.; Van Scheyen J.D.; Murphy D.L., 1980: Platelet mono amine oxidase activity and clomipramine induced mania in uni polar depressed patients

Duncavage M.; Luchins D.J.; Meltzer H.Y., 1982: Platelet mono amine oxidase activity and family history of schizophrenia

Baron M.; Levitt M.; Gruen R.; Kane J.; Asnis L., 1984: Platelet mono amine oxidase activity and genetic vulnerability to schizophrenia

Glover V.; Peatfield R.; Zammit Pace R.; Gawel M.; Rose F.C.; Sandler M.; Littlewood J., 1981: Platelet mono amine oxidase activity and head ache

Malas K.L.; Van Kammen D.P., 1983: Platelet mono amine oxidase activity and long term outcome in schizophrenia and schizo affective disorder

Oreland L.; Wiberg A.; Asberg M.; Traskman L.; Sjostrand L.; Thoren P.; Bertilsson L.; Tybring G., 1981: Platelet mono amine oxidase activity and mono amine metabolites in cerebro spinal fluid in depressed and suicidal patients and healthy controls

Gattaz W.F.; Beckmann H., 1981: Platelet mono amine oxidase activity and personality characteristics a study in schizophrenic patients and normal individuals

Gruen R.; Baron M.; Levitt M.; Asnis L., 1982: Platelet mono amine oxidase activity and schizophrenic prognosis

Davidson J.R.T.; Mcleod M.N.; Turnbull C.D.; White H.L.; Feuer E.J., 1980: Platelet mono amine oxidase activity and the classification of depression

Redmond D.E.Jr; Murphy D.L.; Baulu J., 1979: Platelet mono amine oxidase activity correlates with social affiliative and agonistic behaviors in normal rhesus monkeys

Murphy, D. L.; Redmond, D. E-Jr ; Baulu, J.; Donnelly, C. H., 1978: Platelet mono amine oxidase activity in 116 normal rhesus monkeys relations between enzyme activity and age sex and genetic factors

Propping P.; Friedl W., 1979: Platelet mono amine oxidase activity in 1st degree relatives of schizophrenic patients

Owen F.; Bourne R.C.; Crow T.J.; Fadhli A.A.; Johnstone E.C., 1981: Platelet mono amine oxidase activity in acute schizophrenia relationship to symptomatology and neuroleptic medication

Roth, J. A.; Young, J. G.; Cohen, D. J., 1976: Platelet mono amine oxidase activity in children and adolescents

Young J.G.; Cohen D.J.; Waldo M.C.; Feiz R.; Roth J.A., 1980: Platelet mono amine oxidase activity in children and adolescents with psychiatric disorders

Fowler C.J.; Wiberg A.; Gustavson K H.; Winblad B., 1981: Platelet mono amine oxidase activity in downs syndrome

Kruk, Z. L.; Moffett, A.; Scott, D. F., 1980: Platelet mono amine oxidase activity in epilepsy

Shaskan E.G.; Peszke M.A.; Niederman J.C., 1980: Platelet mono amine oxidase activity in epstein barr and dengue virus infections

Mann, J.; Chiu, E., 1978: Platelet mono amine oxidase activity in huntingtons chorea

Glover V.; Sandler M.; Hughes A.; Hoffbrand A.V., 1980: Platelet mono amine oxidase activity in megalo blastic anemia

Maubach M.; Diebold K.; Friedl W.; Propping P., 1981: Platelet mono amine oxidase activity in patients with affective psychosis and their first degree relatives

Mooney J.J.; Chao F.C.; Orsulak P.J.; Adler S.A.; Schildkraut J.J., 1981: Platelet mono amine oxidase activity in psychiatric disorders the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples

Schuckit M.A.; Shaskan E.; Duby J.; Vega R.; Moss M., 1982: Platelet mono amine oxidase activity in relatives of alcoholics preliminary study with matched control subjects

Wyatt R.J.; Potkin S.G.; Murphy D.L., 1979: Platelet mono amine oxidase activity in schizophrenia a review of the data

Maj M.; Ariano M.G.; Pirozzi R.; Salvati A.; Kemali D., 1984: Platelet mono amine oxidase activity in schizophrenia relationship to family history of the illness and neuroleptic treatment

Koide Y., 1980: Platelet mono amine oxidase activity in schizophrenics kinetic aspects

Schildkraut J.J.; Orsulak P.J.; Schatzberg A.F.; Herzog J.M., 1980: Platelet mono amine oxidase activity in subgroups of schizophrenic disorders

Jones, J. B.; Southgate, J., 1976: Platelet mono amine oxidase activity in the human fetus

Hitzemann R.J.; Sautter F.; Hitzemann B.; Hirschowitz J.; Garver D.L., 1984: Platelet mono amine oxidase activity in the psychoses relationship to symptoms and lithium response

Sullivan, J. L.; Cavenar, J. O-Jr ; Maltbie, A.; Stanfield, C., 1977: Platelet mono amine oxidase activity predicts response to lithium in manic depressive illness

Baron M.; Levitt M., 1980: Platelet mono amine oxidase activity relation to genetic load of schizophrenia

Baron M.; Gruen R.; Levitt M.; Kane J., 1984: Platelet mono amine oxidase and clinical phenomenology of schizophrenia

Rossi, E. C.; Louis, G.; Bieber, M.; Zeller, E. A., 1978: Platelet mono amine oxidase and epinephrine induced platelet aggregation

Agarwal D.P.; Philippu G.; Milech U.; Ziemsen B.; Schrappe O.; Goedde H.W., 1983: Platelet mono amine oxidase and erythrocyte catechol o methyl transferase activity in alcoholism and controlled abstinence

Rampling, R. P.; Carter, S. M. B.; Glover, V.; Sandler, M., 1984: Platelet mono amine oxidase and phenol sulfo transferase ec 2.8.2.1 m form and p form in cancer

Baron M.; Levitt M.; Gruen R., 1983: Platelet mono amine oxidase and plasma amine oxidase effect of anti coagulant and centrifugation technique on platelet yield and enzyme activity

Meltzer H.Y.; Arora R.C.; Jackman H.; Pscheidt G.; Smith M.D., 1980: Platelet mono amine oxidase and plasma amine oxidase in psychiatric patients

Zizolfi S.; Famiglietti L.A.; Del Vecchio M.; Kemali D., 1979: Platelet mono amine oxidase and serum dopamine beta hydroxylase activities in psychotic patients

Alexopoulos G.S.; Lieberman K.W.; Frances R.; Stokes P.E., 1981: Platelet mono amine oxidase during the alcohol withdrawal syndrome

Norman, T. R.; Chamberlain, K. G.; French, M. A.; Burrows, G. D., 1982: Platelet mono amine oxidase ec 1.4.3.4 activity and cigarette smoking

Mosnaim, A. D.; Karoum, F.; Zeller, A.; Callaghan, O. H.; Singh, S. P.; Wolf, M. E., 1982: Platelet mono amine oxidase ec 1.4.3.4 activity and plasma levels of noncatecholic phenethylamines in insulin dependent diabetic subjects

Yu, P. H.; Bowen, R. C.; Davis, B. A.; Boulton, A. A., 1983: Platelet mono amine oxidase ec 1.4.3.4 activity and trace acid levels in plasma of agoraphobic patients

Rice, J.; Mcguffin, P.; Goldin, L. R.; Shaskan, E. G.; Gershon, E. S., 1984: Platelet mono amine oxidase ec 1.4.3.4 activity evidence for a single major locus

Johansson, F.; Von-Knorring, L.; Oreland, L., 1983: Platelet mono amine oxidase ec 1.4.3.4 activity in patients with chronic pain syndrome relationship to personality traits endorphins in cerebro spinal fluid and plasma cortisol

Fowler, C. J.; Von-Knorring, L.; Oreland, L., 1980: Platelet mono amine oxidase ec 1.4.3.4 activity in sensation seekers

Giller, E. Jr ; Jatlow, P.; Bialos, D.; Harkness, L.; Docherty, J. P., 1980: Platelet mono amine oxidase ec 1.4.3.4 and amitriptyline treatment

Summers, K. M.; Brown, G. K.; Craig, I. W.; Littlewood, J.; Peatfield, R.; Glover, V.; Rose, F. C.; Sandler, M., 1982: Platelet mono amine oxidase ec 1.4.3.4 specific activity and turnover number in head ache

Ask A L.; Book J.A.; Heyden T.; Ross S.B.; Unge C.; Wetterberg L.; Eiduson S.; Kobayashi K., 1979: Platelet mono amine oxidase in a pedigree with schizophrenia an inter laboratory project

Smith R.C.; Ho B.T.; Kralik P.; Vroulis G.; Gordon J.; Wolff J., 1982: Platelet mono amine oxidase in alzheimers disease

Shekim W.O.; Davis L.G.; Bylund D.B.; Brunngraber E.; Fikes L.; Lanham J., 1982: Platelet mono amine oxidase in children with attention deficit disorder and hyperactivity a pilot study

Berrettini W.H.; Benfield T.C.; Schmidt A.O.; Ladman R.K.; Vogel W.H., 1980: Platelet mono amine oxidase in families of chronic schizophrenics

Propping P.; Rey E R.; Friedl W.; Beckermann H., 1981: Platelet mono amine oxidase in healthy subjects the biochemical high risk paradigm revisited

Feine, R.; Belmaker, R. H.; Rimon, R.; Ebstein, R. P., 1977: Platelet mono amine oxidase in women with pre menstrual syndrome

Abou Saleh M.T., 1983: Platelet mono amine oxidase personality and response to lithium prophylaxis

Buffoni, F.; Ignesti, G.; Pirisino, R.; Cortesini, C., 1977: Platelet mono amine oxidase plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients

Wise C.D.; Bridge T.P.; Potkin S.G.; Wyatt R.J., 1979: Platelet mono amine oxidase studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups

Baron M.; Levitt M.; Perlman R., 1981: Platelet mono amine oxidase values and genetic heterogeneity in schizophrenia research

Ehsanullah R.S.B.; Turner P., 1981: Platelet mono amine uptake in relatives of patients with huntingtons chorea

Poirier M F.; Loo H.; Dennis T.; Le Fur G.; Scatton B., 1985: Platelet monoamine oxidase activity and plasma 3 4 dihydroxyphenylethylene glycol levels during the menstrual cycle

Lidberg L.; Modin I.; Oreland L.; Tuck J.R.; Gillner A., 1985: Platelet monoamine oxidase activity and psychopathy

Morgenstern H.; Hafez H.M.; Glazer W.M.; Giller E.Jr; Zahner G., 1988: Platelet monoamine oxidase activity and tardive dyskinesia

Bagdy G.; Rihmer Z.; Frecska E.; Szadoczky E.; Arato M., 1986: Platelet monoamine oxidase activity and the dexamethasone suppression test in bipolar depression

Von Knorring A L.; Bohman M.; Von Knorring L.; Oreland L., 1985: Platelet monoamine oxidase activity as a biological marker in subgroups of alcoholism

Bridge T.P.; Soldo B.J.; Phelps B.H.; Wise C.D.; Francak M.J.; Wyatt R.J., 1985: Platelet monoamine oxidase activity demographic characteristics contribute to enzyme activity variability

Trivedi J.K.; Tandon S.K.; Viswanathan P.N.; Gupta A.K.; Sethi B.B., 1987: Platelet monoamine oxidase activity in chronic schizophrenia

Gerbaldo H.; Rozados R.V.; Filinger E.J., 1985: Platelet monoamine oxidase activity in chronic schizophrenics

Schneider L.S.; Severson J.A.; Pollock V.; Cowan R.P.; Sloane R.B., 1986: Platelet monoamine oxidase activity in elderly depressed outpatients

Balon R.; Rainey J.M.; Pohl R.; Yeragani V.K.; Oxenkrug G.F.; Mccauley R.B., 1987: Platelet monoamine oxidase activity in panic disorder

Davidson J.; Lipper S.; Kilts C.D.; Mahorney S.; Hammett E., 1985: Platelet monoamine oxidase activity in posttraumatic stress disorder

Faraj B.A.; Newman S.L.; Caplan D.B.; Ahmann P.A.; Kutner M.; Ali F.M.; Lindahl J.A., 1985: Platelet monoamine oxidase activity in reyes syndrome

Lee C.; Kim C E., 1986: Platelet monoamine oxidase activity in schizophrenic disorder

Elmore J.L.; Evans F.J.; Weinapple M.; Kight Law A., 1988: Platelet monoamine oxidase activity levels and symptom correlates in triathletes

Shekim W.O.; Bylund D.B.; Alexson J.; Glaser R.D.; Jones S.B.; Hodges K.; Perdue S., 1986: Platelet monoamine oxidase and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity

Lykouras E.; Moussas G.; Markianos M., 1987: Platelet monoamine oxidase and plasma dopamine beta hydroxylase activities in non abstinent chronic alcoholics relation to clinical parameters

Lee J P.; Paik I H., 1987: Platelet monoamine oxidase and plasma dopamine beta hydroxylase activity in alcoholics

Fritz, R. R.; Abell, C. W.; Denney, R. M.; Denney, C. B.; Bessman, J. D.; Boeringa, J. A.; Castellani, S.; Lankford, D. A.; Malek-Ahmadi, P.; Rose, R. M., 1986: Platelet monoamine oxidase concentration and molecular activity i. new methods using an monoamine oxidase b specific monoclonal antibody in a radioimmunoassay

Rose, R. M.; Castellani, S.; Boeringa, J. A.; Malek-Ahmadi, P.; Lankford, D. A.; Bessman, J. D.; Fritz, R. R.; Denney, C. B.; Denney, R. M.; Abell, C. W., 1986: Platelet monoamine oxidase concentration and molecular activity ii. comparison of normal and schizophrenic populations

Pandey G.N.; Fawcett J.; Gibbons R.; Clark D.C.; Davis J.M., 1988: Platelet monoamine oxidase in alcoholism

Norman T.R.; Chamberlain K.G.; French M.A., 1987: Platelet monoamine oxidase low activity in cigarette smokers

Funatsu M., 1987: Platelet monoamine oxidase mao activity frontal midline theta activity fm theta and personality traits

Summers K.M.; Andrew B.; Gillespie C.; Watt D.C.; Craig I.W., 1985: Platelet monoamine oxidase specific activity and turnover number in schizophrenics and their families

Nutt D.; Glue P.; Stewart A., 1987: Platelet monoamine receptor binding in alcoholics during withdrawal

Basrur P.K.; Frombach S.; Mcdonell W.N., 1983: Platelet morphology and membrane bound calcium in porcine stress syndrome

Puszkin, E. G.; Maldonado, R.; Spaet, T. H.; Zucker, M. B., 1977: Platelet myosin localization of the rod myosin fragment and effect of its antibodies on platelet function

Marcus A.J.; Safier L.B.; Ullman H.L.; Islam N.; Broekman M.J.; Falck J.R.; Fischer S.; Von Schacky C., 1988: Platelet neutrophil interactions 12s hydroxyeicosatetraen 1 20 dioic acid a new eicosanoid synthesized by unstimulated neutrophils from 12s 20 dihydroxyeicosatetraenoic acid

Buchanan G.R.; Alter B.P.; Holtkamp C.A.; Walsh E.G., 1981: Platelet number and function in diamond blackfan anemia

Jensen P.N.; Glud T.K.; Arnfred T., 1984: Platelet number and platelet volume in healthy young men during exercise and changes in posture

Glud T.; Schmidt E.B.; Kristensen S.D.; Arnfred T., 1986: Platelet number and volume during myocardial infarction in relation to infarct size

Lamparelli, R. D. V.; Baynes, R. D.; Atkinson, P.; Bezwoda, W. R.; Mendelow, B. V., 1988: Platelet parameters part i. platelet counts and mean platelet volume in normal and pregnant subjects

Baynes, R. D.; Lamparelli, R. D. V.; Bezwoda, W. R.; Gear, A. J.; Chetty, N.; Atkinson, P., 1988: Platelet parameters part ii. platelet volume number relationships in various normal and disease states

Meyer S.; More R.; Yarom R., 1987: Platelet pathology in minimal curve idiopathic scoliosis an attempt to predict curve progression

Yarom R.; Muhlrad A.; Hodges S.; Robin G.C., 1980: Platelet pathology in patients with idiopathic scoliosis ultrastructural morphometry aggregations x ray spectrometry and biochemical analysis

Imbert M.; Jarry M.T.; Tulliez M.; Breton Gorius J., 1983: Platelet peroxidase deficiency in a case of myelo dysplastic syndrome with myelo fibrosis

Woessner S.; Lafuente R.; Florensa L., 1986: Platelet peroxidase of circulating thrombocytes in acquired refractory anemias

Suda, J.; Eguchi, M.; Ozawa, T.; Furukawa, T.; Hayashi, Y.; Kojima, S.; Maeda, H.; Tadokoro, K.; Sato, Y.; Et-Al, 1988: Platelet peroxidase positive blast cells in transient myeloproliferative disorder with down's syndrome

Kamiyama R.; Matsuya S.; Muto Y.; Yamaguchi H.; Tsukada T., 1988: Platelet phagocytosis by macrophages in the bone marrow of patients with idiopathic thrombocytopenic purpura as a predictive factor in the effectiveness of splenectomy

Luk S.C.; Musclow E.; Simon G.T., 1980: Platelet phagocytosis in the spleen of patients with idiopathic thrombocytopenic purpura

Glover V.; Lees A.J.; Ward C.; Stern G.M.; Sandler M., 1983: Platelet phenol sulfo transferase activity in parkinsons disease

Abenhaim L.; Kuchel O.; Romain Y., 1981: Platelet phenol sulfo transferase and catecholamines physiological and pathological variations in humans

Campbell N.R.C.; Dunnette J.H.; Mwaluko G.; Van Loon J.; Weinshilboum R.M., 1984: Platelet phenol sulfo transferase and erythrocyte catechol o methyl transferase activities correlation with methyl dopa metabolism

Littlewood J.; Glover V.; Sandler M.; Petty R.; Peatfield R.; Rose F.C., 1982: Platelet phenol sulfo transferase deficiency in dietary migraine

Reiter, C.; Weinshilboum, R., 1982: Platelet phenol sulfo transferase ec 2.8.2.1 activity correlation with sulfate conjugation of acetaminophen

Ciavatti, M.; Michel, G.; Dechavanne, M., 1978: Platelet phospho lipid in stroke

Aktulga, A. Z.; Gurakar, M.; Ulutin, O. N., 1977: Platelet phospho lipids in liver cirrhosis

Breuer J.H.; Harsanyi V.; Solti V.; Hollan S.R., 1981: Platelet phospho lipids in thrombocytosis due to myelo proliferative disorders

Ciavatti, M.; Michel, G.; Dechavanne, M., 1977: Platelet phospho lipids in venous thrombosis after surgical operation

Gergely, P.; Castle, A. G.; Crawford, N., 1980: Platelet phosphorylase kinase ec 2.7.1.38 activity and its regulation by the calcium dependent regulatory protein calmodulin

Bianciardi G.; Weber G.; Toti P.; Widhalm K.; Sinzinger H., 1986: Platelet plasma membrane changes in human type iia hypercholesterolemia

Phillips, D. R.; Agin, P. P., 1977: Platelet plasma membrane glyco proteins evidence for the presence of nonequivalent di sulfide bonds using nonreduced reduced 2 dimensional gel electrophoresis

Phillips, D. R.; Agin, P. P., 1977: Platelet plasma membrane glyco proteins identification of a proteolytic substrate for thrombin

Gartner, T. K.; Williams, D. C.; Phillips, D. R., 1977: Platelet plasma membrane lectin activity

Matsuo M., 1988: Platelet plasmalogens and their compositions of fatty acids in ischemic heart disease

Agam G.; Livne A., 1984: Platelet platelet recognition during aggregation distinct mechanisms determined by the release reaction

Eason C.T.; Pattison A.; Howells D.D.; Mitcheson M.; Bonner F.W., 1986: Platelet population profiles significance of species variation and drug induced changes

Kakaiya R.M.; Katz A.J., 1984: Platelet preservation in large containers

Odink, J.; Sprokholt, R., 1977: Platelet preservation part 1 the use of decrease in light absorbance as a screening method in cryo preservation studies on human platelets

Odink, J., 1976: Platelet preservation part 2 the response of human platelet suspensions to hypotonic stress

Odink, J.; Sprokholt, R., 1976: Platelet preservation part 3 the influence of di methyl sulfoxide and cooling conditions on serotonin uptake velocity and response to hypotonic stress of human platelets

Odink, J.; De-Wit, J. J. F. M.; Janssen, C. L.; Prins, H. K., 1978: Platelet preservation part 4 preparation and cryo preservation of platelet concentrates from fresh and over night stored human blood

Odink, J.; Brand, A., 1977: Platelet preservation part 5 survival serotonin uptake velocity and response to hypotonic stress of fresh and cryo preserved human platelets

Kattlove, H. E., 1974: Platelet preservation what temperature a rationale for strategy

Speijer H.; Govers Riemslag J.W.P.; Zwaal R.F.A.; Rosing J., 1987: Platelet procoagulant properties studied with snake venom prothrombin activators

Trowbridge E.A.; Martin J.F.; Slater D.N.; Kishk Y.T.; Warren C.W., 1983: Platelet production a computer based biological interpretation

Radley J.M.; Hodgson G.S.; Levin J., 1980: Platelet production after administration of anti platelet serum and 5 fluoro uracil

Jackson, C. W.; Edwards, C. C., 1976: Platelet production capacity at intervals after acute thrombocytopenia

Tkacheva T.V., 1981: Platelet production evaluated by the reaction to nonspecific esterase

Mcdonald, T. P., 1978: Platelet production in hypoxic and red blood cell transfused mice

Trowbridge E.A.; Slater D.N.; Kishk Y.T.; Woodcock B.W.; Martin J.F., 1984: Platelet production in myocardial infarction and sudden cardiac death

Burton I.E.; Griffin B.D.; Roberts B.E.; Mcmahon M.J., 1980: Platelet production time in surgery

Boneu B.; Fournie A.; Sie P.; Grandjean H.; Bierme R.; Pontonnier G., 1980: Platelet production time uricemia and some hemostasis tests in pre eclampsia

Jaschonek K.; Karsch K.R.; Weisenberger H.; Tidow S.; Faul C.; Renn W., 1986: Platelet prostacyclin binding in coronary artery disease

Jaschonek K.; Weisenberger H.; Tidow S.; Daiss W.; Renn W.; Ostendorf P., 1986: Platelet prostacyclin binding in smokers

Turney J.H.; Williams L.C.; Fewell M.R.; Parsons V.; Weston M.J., 1980: Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy

Davies G.E.; Palek J., 1982: Platelet protein organization analysis by treatment with membrane permeable cross linking reagents

Schafer A.I.; Maas A.K.; Ware J.A.; Johnson P.C.; Rittenhouse S.E.; Salzman E.W., 1986: Platelet protein phosphorylation elevation of cytosolic calcium and inositol phospholipid breakdown in platelet activation induced by plasmin

Hanai K.; Kato H.; Matsuhashi S.; Morita H.; Raines E.W.; Ross R., 1987: Platelet proteins including platelet derived growth factor specifically depress a subset of the multiple components of the response elicited by glutathione in hydra

Bevers E.M.; Comfurius P.; Nieuwenhuis H.K.; Levy Toledano S.; Enouf J.; Belluci S.; Caen J.P.; Zwaal R.F.A., 1986: Platelet prothrombin converting activity in hereditary disorders of platelet function

Nishimura, J.; Hamasaki, N.; Minakami, S., 1978: Platelet pyruvate kinase ec 2.7.1.40 2 inter convertible forms of the enzyme


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close